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ABSTRACT OF DISSERTATION

CHARACTERIZATION OF JABBA, A RICIN-RESISTANT MUTANT OF
LEISHMANIA DONOVANI
The abundant cell-surface lipophosphoglycan (LPG) of Leishmania parasites
plays a central role throughout the eukaryote’s life cycle. A number of LPG-defective
mutants and their complementing genes have been isolated and have proven invaluable in
assessing the importance of LPG and related glycoconjugates in parasite virulence. While
ricin agglutination selection protocols frequently result in lpg- mutants, one L. donovani
variant we isolated, named JABBA, was found to be lpg+. Procyclic (logarithmic)
JABBA expresses significant amounts of a large-sized LPG, larger than observed from
procyclic wild-type but similar in size to LPG from wild-type from metacyclic
(stationary) phase.
Structural analysis of the LPG from logarithmically-grown JABBA by capillary
electrophoresis protocols revealed that it averaged 30 repeat units composed of the
unsubstituted Gal(β1,4)Man(α1)-PO4 typical of wild-type L. donovani. Analysis of
JABBA LPG caps indicated that 20% are the disaccharide Glc(β1,2)Man, trisaccharide
Gal(β1,4)[Glc(β1,2)]Man, and tetrasaccharide Gal(β1,4)[Glc(β1,2)Man(α1,2)]Man in
addition to wild-type Gal(β1,4)Man and Man(α1,2)Man and Gal(β1,4)[Man(α1,2)]Man
terminating caps, These glucose containing isoforms were absent in stationary parasites.
Consistent with these structural observations, analyses of the relevant
glycosyltransferases in JABBA microsomes involved in LPG biosynthesis showed a twofold increase in elongating mannosylphosphoryltransferase activity and up-regulation of a
β-glucosyltransferase activity. The β-glucosyltransferase in both JABBA and wild-type
in vitro produced a β-glucosidase sensitive and β-galactosidase sensitive trisaccharide,
indicative of the mannose of repeating units and caps being used in substrate, novel in
comparison to other Leishmania species. Furthermore, the caps of JABBA LPG are
cryptic in presentation as shown by the loss of binding by the lectins ricin, peanut
agglutinin and concanavalin A and reduced accessibility of the terminal galactose
residues to oxidation by galactose oxidase.

These results indicate that LPG from JABBA is intriguingly similar to the larger
LPG in wild-type parasites that arises following the differentiation of the non-infectious
procyclic promastigotes to infectious, metacyclic forms, and has a unique βglucosyltransferase not active in vivo in wild-type parasites.
KEYWORDS: Parasites, Glycosyltransferases, Ricin Agglutinin, Leishmania,
Lipophosphoglycan.
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Chapter I
Introduction
The World Health Organization lists leishmaniasis as one of its top six tropical
diseases for research and control efforts. Approximately 350 million people (Kaye, P. and
Scott, P. 2011) in 88 countries are at risk, with 1-2 million new cases a year, making
leishmaniasis the second most common parasitic disease in the world behind malaria.
There are three primary forms of leishmaniasis, which range from self-healing ulcers to
disfiguring or deadly infections. The host’s immune system and the species of parasite
have been shown to cause the varying state of illness. Drug treatments are few, most are
toxic, and resistance to those drugs is showing up in areas where leishmaniasis is
endemic. Vaccination development is slow, and the focus has been on vaccination of
non-human reservoirs.
Leishmania parasites lead a complex life cycle, and have a complex glycocalyx to
protect them. They have two forms in this cycle, the promastigote, and an amastigote.
The promastigote is ingested by a sand fly when it consumes a blood meal from an
infected mammal, it will then reside in the sand fly’s midgut for approximately a week,
undergoing metacyclogenesis to become the infectious parasite. When the parasites
release from the midgut they migrate to the mouth parts to be injected at the next blood
meal. In the newly infected mammal, the parasites travel to the macrophage, where they
reside in the phagolysosome change into amastigotes, the form during the course of
infection.
In order to survive the sand fly midgut, the mammalian bloodstream, and the
mammalian macrophage, Leishmania have an extensive glycocalyx containing a variety
of glycolipids, GPI-anchored proteins, and secreted glycoproteins. Lipophosphoglycan
(LPG) is the dominant molecule coating the surface of promastigotes, found in excess of
one million copies. The basic structure of LPG is a conserved glycan core and a
phospholipid anchor, a developmentally regulated number of disaccharide repeating
units, and a neutral oligosaccharide cap. LPG plays a role in midgut attachment, parasite
virulence, and host immune response.
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Current research in this lab has focused on identifying critical molecules in the
LPG biosynthesis pathway. The unique structures found on LPG have made it a potential
drug target with potentially fewer toxic side effects compared to most anti-protozoal
drugs. Parasites were exposed to mutagens in order to generate a selection of mutant
strains, and parasites with abnormal LPG structures were selected for further study. This
dissertation introduces JABBA, the first over-expressing LPG mutant, and analyzes the
structure of its mutant LPG and the biochemical causes for the changes. Lastly, we utilize
lectins to determine how the altered LPG structure could affect the parasites life cycle.
1. Leishmaniasis
Leishmaniasis is caused by multiple species, found in multiple countries, and
presents a variety of clinical manifestations. Cutaneous leishmaniasis is found
predominantly in Africa, the Mediterranean, the Middle East, and Asia and parts of India.
The species that cause the bulk of cutaneous leishmaniasis are L. major, L. tropica, L.
mexicana (western hemisphere), and L. aethiopica (Berman, J.D. 1997;Grimaldi, G., Jr.,
et al. 1989). The disease can develop within a few days or over years after the bite from
an infected sand fly, presenting with a lesion that is covered by a thin crust and slowly
spreads. These sores can heal on their own leaving unpigmented scars. A secondary case
can occur called diffuse cutaneous leishmaniasis, causing nodules and plaques to form
under the skin of extremities months or years after the initial infection. Another unique
form of cutaneous leishmaniasis is mucocutaneous leishmaniasis (Berman, J.D. 1997),
localized from Mexico to Argentina, and caused by L. braziliensis and L. panemaensis.
After an initial cutaneous infection has ran its course, the parasites metastasize to the
mucus membranes, forming ulcers which destroy the mucus membranes of the nose and
mouth.
Visceral leishmaniasis, or “kala azar” in India, is found in the Mediterranean,
Russia, China, India, and East Africa and caused by parasites of the L. donovani
complex. In the western hemisphere, the disease is caused by L. tropica, L. amazonesis,
and L. chagasi (Berman, J.D. 1997;Grimaldi, G., Jr., et al. 1989). Symptoms include
fever, weight-loss, anemia, and swelling of the spleen and liver; untreated, mortality is
guaranteed. As with cutaneous leishmaniasis, the incubation period is a few days to a
2

year after bite from infected sand fly. Currently, co-infection with HIV has become a
major concern with visceral leishmaniasis (Montalban, C. 1991).
The best treatment option available currently is miltefosine, a drug given orally,
rather than intravenously (Coelho, A.C., et al. 2014). Miltefosine is a derivative of
phosphadtidylcholine, and was approved by the FDA for the treatment of all
leishmaniases in 2014. However, during 2013, in Asia Minor and India approximately
20% of patients given miltefosine relapsed within a year (Vanaerschot, M., et al.
2014a;Vanaerschot, M., et al. 2014b)
Other treatments for leishmaniasis rely on pentavalent antimonial drugs which
inhibit glycolytic enzymes and fatty acid oxidation in amastigotes (Markell, 1999).
Sodium stibogluconate and N-methylgucamin antimonials require a 20 day course of
medication (Berman, J.D. 1997;Grimaldi, G., Jr. and Tesh, R.B. 1993) but the side effects
of these treatments require monitoring and in locations affected by leishmaniases the
overall course is often not completed.
Pentamidine and Amphotericin B are possible forms of treatment, with the latter
proving extremely effective. Both of these drugs however are toxic to humans at the
necessary therapeutic levels (Berman, J.D. 1997;Herwaldt, B.L., et al. 1992;Melby, P.C.
2002), with side effects intense enough that patients must be medically monitored.
Cutaneous leishmaniasis does not require treatment, and antibodies developed from
untreated cutaneous leishmaniasis are effective against future cases in most people.
Vaccinations against leishmaniasis have been proposed in a variety of forms.
Recently a number have focused on different proteases in New World species
(Zahedifard, F., et al. 2014), some that could even be administered intra-nasally (de
Matos Guedes, H.L., et al. 2014). A uniform problem has been found in translating
vaccine designs to humans, as most vaccines with favorable results in mice do not prove
successful in humans (de Matos Guedes, H.L., et al. 2014). The newest technique
attempts to use live attenuated parasites to produce an immune response, with moderate
success (Dey, R., et al. 2014). The biggest leap forward overall in working to control
leishmaniasis is the development of two commercially available vaccines for dogs
(Fernandes, C.B., et al. 2014), a frequent mammalian host for the parasite.
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2. Life Cycle
Leishmania sp. are members of the order Kinetoplastida, in the family
Trypanosmatida. A number of infectious parasites reside in the same family, including
the highly prevalent Chagas Disease. Characteristic of the Kinetoplastid family, the
parasite has a kinetoplast, a single tubular mitochondrion of condensed DNA consisting
of roughly 20,000 minicircles of DNA and 20-50 maxicircles, at the base of the
flagellum. The parasites have a single nucleus and either an elongated body with a long
protruding flagellum or a short body with a nonprotruding flagellum. Leishmania and
some other trypanosomes are heteroxenous, others, such as Herptomonas, are
monoxenous.
Leishmania have a digenetic life cycle (Turco, S.J. and Descoteaux, A. 1992), a
model of which is illustrated in Figure 1. Parasites are ingested by the sand fly during its
blood meal, and they proceed to differentiate in the alimentary tract of the sand fly. In the
midgut the parasites attach to the epithelium using insect lectins (Kamhawi, S., et al.
2004;Sacks, D.L., et al. 1995), and over the course of approximately a week the parasites
undergo metacyclogenesis and transition to the metacyclic promastigote (de Assis, R.R.,
et al. 2012;Sacks, D.L. 1989). While it has not been seen in the wild, co-infection of a
sand fly can result in DNA exchange between species (Akopyants, N.S., et al.
2009;Inbar, E., et al. 2013). Promastigotes, the life cycle form in the sand fly, are spindle
shaped, 10-15 µM in length, and 2-3 µM in diameter with the flagellum at the basal body
of the anterior pole and highly motile for its migration to the proboscis.. Approximately
10 different forms have been described, varying by species and sand fly vector (Lawyer,
P.G., et al. 1990).
A variety of systems are used to culture promastigotes. They grow as a
heterogenous population in liquid culture, with population percentages varying based on
culture conditions and growth phase. The parasites prefer temperatures about 24-26 ºC
and a neutral to slightly acidic pH, similar to the conditions found in the sand fly midgut.
The actual infectivity of a liquid culture varies, it is estimated that 10% of the stationary
phase culture manages to fully differentiate into metacyclic parasites. Lectins are used to
select for the unique cell surface antigens found on metacyclics, isolating that population
for further study (Sacks, D.L. and da Silva, R.P. 1987;Sacks, D.L. and Perkins, P.V.
4

1985). For example, peanut agglutinin is used to identify metacyclic L. donovani
parasites due to their resistance to agglutination. Recently algorithms have been
developed to identify metacyclic parasites based on the slight changes in cell architecture,
including an extreme narrowing of the cell (Berg, M., et al. 2013).
In the mammalian host, the aflagellated amastigote develops in the
parasitophorous vacuole contained in the macrophage (Turco, S.J. and Descoteaux, A.
1992), where it continues to replicate until it lyses the macrophage and spills out to infect
other cells. The amastigotes are round, approximately 2-3 µM in diameter and lack a
visible flagellum, as it does not extend past the cell circumference. Amastigotes can be
grown axenically (Bates, P.A., et al. 1988;Doyle, P.S., et al. 1991), a low pH and high
temperature are required to trigger the transformation (Zilberstein, D. and Shapira, M.
1994).
3. Structure of Lipophosphoglycan
Leishmania parasites encounter a number of hostile environments between the
sand fly and host, and thus require an extensive, dense, glycocalyx (seen in Figure 1.2)
for survival and protection. The glycocalyx consists of lipophosphoglycan (LPG),
glycoinositolphospholipids (GIPLs) (McConville, M.J. and Blackwell, J.M.
1991;Orlandi, P.A., Jr. and Turco, S.J. 1987;Turco, S.J., et al. 1987), excreted
proteophosphoglycans (PPG) (Ilg, T., et al. 1994a;Ilg, T., et al. 1996;Ilg, T., et al. 1994b)
and secreted acid phosphatase (sAP) (Lovelace, J.K. and Gottlieb, M. 1986). LPG is one
of the dominant molecules in the promastigote phase, found all over the cell surface
including the flagellum with approximately one million copies per cell.
LPG consists of four domains: (i) a lipid anchor, (ii) glycan core, (iii)
Gal(β1,4)Man(α1)-PO4 repeating units, and (iv) an oligosaccharide cap structure
(Descoteaux, A. and Turco, S.J. 1999;Turco, S.J. and Descoteaux, A. 1992). The lipid is
a 1-O-alkyl-2-lyso-phospatidyl(myo)inositol, containing an aliphatic C24 or C26
unbranched, saturated hydrocarbon. The glycan core contains an unacylated glucosamine,
2 mannopyranoses, 2 galactopyranoses, and a unique galactofuranose residue. L.
donovani and L. mexicana contain a Glc(α1)-PO4 attached to the C-6 hydroxyl of the
proximal mannose via a phosphodiester bond (Ilg, T., et al. 1992;Turco, S.J., et al. 1989).
5

The core, lipid, and repeating unit backbone are highly conserved among species,
while the distinguishing variations between species are found in the side chains attached
to the repeating units and the caps (Figure 1.3), with the C-3 of the galactosyl residue the
most common location for modifications. L. donovani isolated from Sudan contains no
side-chain modifications (Turco, S.J., et al. 1987), while the Indian isolate contains one
or two β-glucosyl residues linked every few repeating units (Mahoney, A.B., et al. 1999).
L. major contains 1-4 β-galactosyl chains terminated with arabinosyl (Dobson, D.E., et
al. 2003b;Sacks, D.L., et al. 1990), L. mexicana contains β-glucosyl chains, and L.
tropica is the most complex with over 19 different types of glycans (Soares, R.P., et al.
2004). L. aethopica is the only LPG found that contains α-mannosyl side chains linked to
the C-2 of the mannosyl residue (McConville, M.J., et al. 1995). The caps are frequently
varied, the common structure found in L. donovani is the trisaccharide
Gal(β1,4)[Manα1,2]Man, and L. major has a dominant Man(α1,2)Man cap.
LPG is the primary ligand for binding to the midgut epithelium of the sand fly.
The developmentally regulated changes are known to help in both attachment and
eventual detachment from the midgut. This includes an increase in repeating units from
approximately 15 to 30 as the parasite undergoes metacyclogenesis and potentially
changes in side chains, in the case of L. major, there is a downregulation in the number of
galactosyl side chains and capped with an arabinosyl residue. This, along with the
changes in the number of repeating units, helps facilitate its release from the sand fly gut
(Pimenta, P.F., et al. 1992;Volf, P., et al. 2014). L. donovani uses the increase in
repeating units alone, and this increase has been shown to hide the terminal cap from
lectin accessibility in vitro (Sacks, D.L., et al. 1995).
LPG molecules are still expressed in the amastigote stage, but are extremely
downregulated, with no more than 1000 molecules per cell (Schneider, P., et al. 1993). In
L. major, these LPG molecules are biochemically distinct from the promastigote stage,
including about 36 repeating units, with 70% of them unsubstituted. The substitutions
include either glucosyl or galactosyl chains, with a maximum of 11 residues attached to a
repeating unit and a predominantly Gal(β1,4)Man cap (Moody, S.F., et al. 1993).
There are some excreted molecules of LPG (Slutzky, G.M., et al. 1979)both with
and without the lipid anchor. Those without the lipid are called phosphoglycans (Greis,
6

K.D., et al. 1992). While the reason for this variation is not quite understood, those with
the lipid are thought to arise through the interaction of albumin in the media with LPG on
the cell surface causing this turnover.
4. Other Cell Surface Glycoconjugates
Leishmania produce a number of other glycoconjugates which will be discussed
here.
A. Glycoinositolphospholipids
Glycoinsoitolphospholipids (GIPLs) are low molecular weight glycolipids that are
expressed on the cell surface; they can resemble protein anchors, but do not explicitly
anchor proteins (McConville, M.J., et al. 1993;McConville, M.J., et al. 1994;Turco, S., et
al. 1994). They are expressed in extremely high copy number, and have three basic types:
Type 1 resembles protein GPI anchors, Type 2 resembles those of LPG glycan core, and
a third type that is expressed as a hybrid of the two. Type I and the hybrid differ in the
lipid composition, as they contain an alkyl-acyl-PI with shorter chains than LPG, while
Type 2 produce a heterogeneous mixture. Little is known about the functions of GIPLs,
but they are a major constituent of the amastigote cell surface, likely conferring
protection to some capacity. They have been demonstrated to modulate signal events in
the macrophage such as nitric oxide synthesis and the oxidative burst(McNeely, T.B., et
al. 1989;Proudfoot, L., et al. 1995b),(Schofield, L., et al. 1996;Tachado, S.D., et al.
1997). The enzymes in GPIL biosynthesis have been demonstrated to be essential for
virulence (Ilgoutz, S.C., et al. 1999)
B. gp63
With approximately 500,000 copies per cell, gp63 is the major protein found on
the surface of promastigote parasites, where it makes up a total of 1% of all cellular
protein. The production of gp63 is downregulated in the amastigote stage of the life cycle
and is found only in the flagellar pocket.
The importance of the molecule is not well understood. It is seen to be
proteolytically active against a number of molecules (Schlagenhauf, E., et al. 1998), and
is considered a possible ligand for complement components. The high-mannose
oligosaccharides found on its surface could be used for cell invasion using the mannose7

fucose receptor. Overall, there is conflicting data as L. mexicana lacking gp63 suffers no
apparent detriment in macrophages or in a mouse model of infection (Hilley, J.D., et al.
2000).
C. Secreted acid phosphatase
All promastigotes, save L. major, release secreted acid phosphatase (sAP) from
the flagellar pocket (Bates, P.A., et al. 1989;Lovelace, J.K. and Gottlieb, M.
1987;Stierhof, Y.D., et al. 1994) and can be found in cellular media. Old World strains of
Leishmania, including L. donovani, release mono or oligomeric sAPs, while New World
strains release a filamentous sAP (Ilg, T., et al. 1999;Ilg, T., et al. 1994a). L. donovani
sAPs are heavily glycosylated on the C-terminal serine or threonine domains via
phosphodiester linkages, and have about 32 Gal(β1,4)Man(α1)-PO4 repeating units. In
contrast, L. mexicana is oligomannosylated.
D. Proteophosphoglycan
There are a number of types of proteophosphoglycan (PPG): filamentous PPG
(fPPG), GPI-anchored form (mPPG), and an amastigote, non-filamentous form (aPPG)
(Ilg, T., et al. 1994b;Stierhof, Y.D., et al. 1994). fPPG is 95% phosphoglycans, while the
protein component is primarily serine, alanine, and proline. The serine molecules are
phosphoglycosylated with the repeating units Gal(β1,4)Man(α1)-PO4 terminated with
small cap structures. There is no obvious evidence for its function, but hypotheses
suggest that it traps the parasites in the midgut or deters the ingestion of a second blood
meal (Killick-Kendrick, R., et al. 1988).
aPPG has a defined polypeptide backbone with modified phosphoglycans, both
common and novel structures, present on the serine residues (Ilg, T., et al. 1998). In the
parasitophorous vacuole, the concentrations of aPPG can be as high as mgs/ml (Ilg, T., et
al. 1995) and contributes to the overall size of the vacuole. These have been shown to
activate the complement cascade.
5. Functions of LPG
A. In the sand fly vector
Leishmania species use the sand flies of two primary genera and many species as
its vector. Old world strains of Leishmania use Phlebotomus spp. and New World strains
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use Lutzomyia. As of this writing, two different capabilities of binding (LPG dependent
and LPG independent) have been established, non-permissive and permissive vectors
(Jecna, L., et al. 2013). In the case of L. major, the primary vector is P. papatsi, and is
referred to as the non-permissive vector; P. perniciosus is the permissive vector.
Using L. major mutants lacking LPG it has recently been shown that the nonpermissive, or primary, vector has an explicitly LPG dependent mechanism of binding to
the mid-gut epithelium. This had been demonstrated in other capacities over the years
using purified LPGs (Butcher, B.A., et al. 1996;Pimenta, P.F., et al. 1992). At the same
time, a non-permissive species binding has been established that exhibits a non-LPG
dependent mechanism for binding to the midgut. Parasite attachment is critical as it
allows the parasite to undergo the life cycle progression of metacyclogenesis without
being excreted (Sacks, D.L. and Perkins, P.V. 1984;Sacks, D.L. and Perkins, P.V. 1985).
The lengthening of LPG from 15 repeating units to 30 repeating units results in
detachment from the epithelium (Sacks, D.L., et al. 1995). Data has shown that in L.
major and nonpermissive binding, in addition to the increase in repeating units, the
capping of β-galactosyl chains with an arabinosyl residues obscures the motif from the
insect lectins to aid in detachment. In L. donovani (Sudanese isolate) the caps lose
accessibility to lectins, which most likely allows for the detachment from the midgut and
migration to the mouth parts. The L. donovani (Indian isolate) has been shown to rely on
the glucose side chains in vitro for the binding of the parasite to the insect midgut, and
that the decrease in glucose as it progresses through metacyclogenesis aids in detachment
(Mahoney, A.B., et al. 1999). The three dimensional structure of LPG is critical to the
parasite’s attachment in the sand fly and subsequent release for the continuation of its life
cycle.
B. In the mammalian bloodstream
Leishmania parasites must use the host immune cells to gain access to the
macrophage which is normally used to eliminate pathogens. Upon initial infection in the
bloodstream, the promastigotes are exposed to complement mediated lysis by
complement factors. Logarithmic phase procyclic promastigotes are sensitive to fresh
blood serum and lysis, while stationary phase promastigotes are increasingly resistant to
lysis (Franke, E.D., et al. 1985;Puentes, S.M., et al. 1988). When compared to
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logarithmic-phase L. major, peanut agglutinin purified metacyclics show that
complement lysis does not affect binding.
Metacyclic parasites manage to activate the complement cascade via the classical
pathway, as C3b is bound on the surface. The membrane attack complex of traditional
cascade occurs by cleavage of the factors. L. major cannot have C5b-9 inserted on its
surface, essentially forming a protective barrier (Puentes, S.M., et al. 1990;Puentes, S.M.,
et al. 1989;Puentes, S.M., et al. 1988). In the case of L. donovani (Sudanese isolate), only
inactive C3b is bound to LPG, which does not result in activation of the C5 convertase
(Puentes, S.M., Dwyer, D.M., et al. 1989), which will later help with a neutral
phagocytosis by the macrophage. Bound C3 can then be released by proteolytic cleavage.
Gp63 can cleave active C3b to its inactive form. In addition to complement, mannanbinding protein can bind to the caps and trigger the complement cascade (Descoteaux, A.
and Turco, S.J. 1999).
C. In the mammalian macrophage
LPG and gp63 are the primary parasite receptors for binding to the macrophage;
CR1, CR3, and the mannose-fucose receptor are the primary receptors for the
macrophage. Inactive C3b allows for opsonization through CR1 and CR3 (Mosser, D.M.
and Edelson, P.J. 1985), though L. donovani can bind in the absence of these through the
mannose-fucose receptor with a mannose-terminating cap (Mosser, D.M., et al. 1992).
Binding through CR3 triggers phagocytosis without the oxidative burst (Wright, S.D. and
Silverstein, S.C. 1983) allowing for easy entry into the macrophage while also inhibiting
IL-12 induced cell-mediated immunity (Descoteaux, A. and Turco, S.J. 1999). The
multiple ways Leishmania parasites can enter immune cells allows for initial entry to
Langerhans cells in the skin, where inducible nitric oxide synthase allows for the parasite
to outwit the immune system (Alexander, J., et al. 1999).
After endocytosis the parasite enters a phagosome, referred to as the
parasitophorous vacuole, where a series of fusion events occur that allow the vacuole to
become the mature phagolysosome. This is a highly acidic and hydrolase rich
environment that allows for amastigote development. The promastigotes have survival
techniques to allow for existence prior to this conversion, primarily LPG, secondarily
secreted acid-phosphatase and proteophosphoglycan, all of which include the same basic
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repeating unit structure. As amastigotes bear little LPG, these other molecules are thought
to protect the parasite in this stage. For example, L. mexicana produces a vacuole
approximately 70% of the size of the host, which is full of copious amounts of these
materials (Peters, C., et al. 1997).
As the primary mechanism for protection for promastigotes, LPG has been
investigated using LPG defective mutants that are unable to establish infection in the
macrophage phagolysosome. Mutants of L. donovani with LPG shorter than 5 repeating
units are unable to inhibit phagosome-endosome fusion (Desjardins, M. and Descoteaux,
A. 1997). Mutants lacking repeating units have also been shown to have the
phagolysosome rapidly mature and acquire rab7 and LAMP1, markers for this
maturation, while wild-type promastigotes do not (Scianimanico, S., et al. 1999).
The importance of LPG in establishing infection within the macrophage has also
been shown by immunofluorescence and anti-LPG antibodies appearing on the cell
surface within 5-10 minutes post-infection (Tolson, D.L., et al. 1990). L. donovani
promastigotes are thought to inhibit the phagosome-endosome fusion mentioned above
through steric hindrance. During endocytosis, LPG molecules are shed, and they
intercalate into the outer leaflet of the plasma membrane of the phagosome (Miao, L., et
al. 1995).
D. Inhibition of hydrolytic enzymes
While there is a dramatic decrease in the amount of LPG produced as the parasite
transforms into the amastigote stage, the relatively small amount produced may still be
important. The conversion results in a decrease of LPG from a few million molecules per
cell to less than 1000 in the amastigote. Some data have suggested that LPG blocks
lysosomal hydrolases. LPG coated erythrocytes are resistant to cytolysis compared to
uncoated erythrocytes (Eilam, Y., et al. 1985), though no exact understanding of this
mechanism is known.
E. Chelation of Calcium
The phosphate of LPG molecules can chelate calcium, which may have important
impacts on the survival of the amastigote in the macrophage. The endocytosis of LPG
coated blood cells, resistant to cytolysis, show an increase in intracellular calcium,
possibly through LPG binding. The binding of calcium to LPG does not disturb the
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structure, and this would impair signal transduction, critically through protein kinase C
(Eilam, Y., et al. 1985;Homans, S.W., et al. 1992;Kane, M.M. and Mosser, D.M. 2000).
Other evidence has shown LPG can chelate other ions as well, particularly divalent
cations, preventing production of radicals during the oxidative burst (Turco, S.J. and
Descoteaux, A. 1992).
F. Inhibition of Host Signaling Pathways
Leishmania parasites have many unique strategies to disrupt the function of the
macrophages and turn off the microbicidal functions. Leishmania parasites and their LPG
have been shown to interrupt the oxidative burst and radical synthesis, modulate
macrophage apoptosis, inhibit antigen presentation and T-cell stimulation, nitric oxide
production, and interfere with IL-12, INF-γ, and TNF-α. LPG is selective for the
regulatory domain only. The regulatory domain allows for binding of diacylglycerol,
calcium, and phospholipids; the 1-O-alkylglycerol moiety of LPG is the most effective
inhibitory factor. In vitro LPG inhibits protein kinase C (McNeely, T.B. and Turco, S.J.
1987). There is some inhibition of PKC from the repeats, but LPG is required to be intact
for this, individual repeating units do not work (McNeely, T.B., et al. 1989). An
alternative hypothesis has been presented that LPG disturbs the lipid bilayer and alters
the properties, preventing PKC insertion and subsequent activity (Giorgione, J.R., et al.
1996). This is a possibility as it inhibits PKC from an opposing monolayer. LPG
mediated inhibition may disrupt other PKC-dependent events , including c-fos gene
expression and macrophage chemotaxis (Descoteaux, A. and Turco, S.J. 1999). GIPLs
also inhibit PKC, but as they have no repeating units, they most likely act through a
different mechanism.
The nitric oxide produced by macrophages is a key regulator in pathogen
destruction through the induction of inducible nitric oxide synthase in response to signals
from invaders such as lipopolysaccharide. LPG-like treatment inhibited nitric oxide
synthesis in a time and dose dependent manner (Proudfoot, L., et al. 1995a). Full length
LPG had no effect, but repeating units alone diminished the production of nitric oxide
(Proudfoot, L., et al. 1996). LPG associated protein kinetoplast membrane protein 11
decreased iNOS activity due to its similarity to L-arginine, a known inhibitor of iNOS
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(Jardim, A., et al. 1995). Production of nitric oxide is directly correlated with inhibiton of
leishmanicidal activity.
G. Oxidative Burst Metabolite Scavenging
Macrophages use the synthesis of arachidonic acid metabolites and oxidative
metabolism as its key regulators for killing foreign organisms. NADPH oxidase is the
primary source as it produces super-oxide and hydrogen peroxide (Nathan, C. and Shiloh,
M.U. 2000). The Gal(β1,4)Man(α1)-PO4 repeat units of LPG may protect the
promastigote from the oxidative burst by scavenging the cytocidal products (Chan, J., et
al. 1989;el-On, J., et al. 1990).
H. Cytokines
Manipulation of cytokine production alters the immune response to the invasion
of Leishmania parasites, and protects the parasite by altering antigen presentation.
Leishmania infected macrophages do not produce IL-12, without which there is no INF-γ,
and no helper T-cell differentiation. Leishmania selectively inhibits IL-12 production,
thought to be a response as excess IL-12 may cause tissue damage detrimental to the
parasite and its survival. LPG selectively suppresses cytokine production as inhibition of
IL-1β gene transcription by LPG as a gene silencer through a specific sequence within the
IL-1β promoter (Hatzigeorgiou, D.E., et al. 1996).
6. LPG Biosynthesis
A. Core-Lipid Biosynthesis
Biosynthesis of the lipid portion of LPG is not well understood, though it is
proposed to begin with the formation of a 1-O-alkyl-2-acyl-phosphatidylinositol. Early
data (Hart, D.T. and Opperdoes, F.R. 1984) suggest this begins with the use of dihydroxy
acetone phosphate acyltransferase (DHAP) which acylates the C-1 position of the lipid.
Reduction by NADPH and acylation at the C-2 results in the formation of 1-O-alkyl-2acyl phosphatidic acid. On the cytoplasmic side of the endoplasmic reticulum, a
glucosamine unit is added and a flippase transfers it to the luminal leaflet where a
mannosyltransferase adds a Man(α1,4) unit. It has been suggested that up until this point,
the synthesis of GPI anchors for proteins and LPG is the same (Ralton, J.E. and
McConville, M.J. 1998). LPG synthesis continues in the Golgi where the second
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mannose is added to the core. A unique galactosylfuranose residue is then added (Ilgoutz,
S.C., et al. 1999), and synthesis is continued with the addition of two more galactose
molecules to give a final core structure of Gal(α1,6)Gal(α1,3)Galf(β1,3)[Glcα1PO46]Man(α1,3)Man(α1,4)GlcN(α1,6). At some stage during this process, fatty acid
remodeling occurs, losing the C-2 fatty acid to yield the mature 1-O-alkyl-2-lysophosphatidyl(myo)inositol anchor. While having structures similar to this point, GIPLs
are synthesized via a different pathway, where the intermediates are controlled and
isolated from the copious production of LPG (Proudfoot, L., et al. 1995b).
B. Repeating Unit Biosynthesis
The start of repeating unit biosynthesis begins with an initiating
mannosylphosphoryltransferase (iMPT). The iMPT recognizes the Gal(α1,6)Gal of the
core, the same motif found in stachyose. Mannose-phosphate transfer has been shown to
be most likely localized to the golgi, as all studies have shown the necessary GDPMannose transporter is localized in the golgi (Figure 1.4). The activity was first
characterized by Mengeling and Turco (1997), and has been shown to be downregulated
in amastigotes. An in vitro assay performed by Carver and Turco (1992) established that
repeating unit biosynthesis continues by alteration of two enzymes; the
mannosylphosphoryltransferase and a galactosyltransferase.
The continuing synthesis of repeating units requires the use of an elongating
mannosylphosphoryltransferase (eMPT), shown to be different than an iMPT activity
through the use of the ricin-resistant mutant JEDI (Descoteaux, A., et al. 1998). The
eMPT recognizes Gal(β1,4)Man (Figure 1.4). There is a third
mannosylphosphoryltransferase present responsible for the addition of the Man-P to the
serine of proteoglycans (Moss, J.M., et al. 1999). The eMPT has been shown in a number
of species, including L. donovani, to require the negative charge of a phosphodiester, the
C-6 hydroxyl of the α-mannosyl residue and C-6’-hydroxyl of β-galactosyl residue for
substrate recognition (Brown, G.M., et al. 1996;Routier, F.H., et al. 2000). While there is
a consensus that there are 3 MPTs, there is a running debate over the existence of two
separate eMPTs: one required for the addition of repeating units to form the procyclic
length of 15 units and a separate enzyme that adds the repeating units required for
metacyclic production. If there is not a second eMPT, there is an extensive regulatory
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mechanism of the single eMPT controlling the number of repeating units during the life
cycle.
C. Cap Biosynthesis
The terminating repeating unit of the LPG molecule is referred to as the cap, the
creation of which involves the same enzymes, and can range from a single mannose to a
full repeating unit. In the L. donovani (Sudanese isolate) there can be a oligo-mannosyl
cap produced, linked α1,2 to the terminal repeating unit mannosyl residue. Other strains
of Leishmania produce different cap variants based on the side-chain glycosyltransferases
the parasite uses in the production of its LPG, which are discussed below.
D. Side Chain Biosynthesis
As mentioned previously there are three types of LPG: Type I has no side chains,
such as L. donovani, Type II has side chains on the C-3 of the galactose, and Type III has
side chains on the C-2 of the mannose. The only Type III LPG characterized to date is
found on L. aethiopica which adds α-mannosyl chains. The only side chain
glycosyltransferases characterized are those of Type II, adding side chains to the C-3 of
the galactosyl residue. Side chain glycosyltransferases are critically regulated, as the
eMPTs, their presence or absence affects vector choice and competence. Recently in the
case of L. major, it has been identified that in certain vectors where the insect lectins
aren’t directly recognizable to the side chains of L. major, there is an entirely different
mechanism for mid-gut binding used by the parasite. In most vectors, the LPG must
match insect mid-gut lectins.
The best studied group of side-chain glycosyltransferases are those involved in
the addition of the side chains in L. major (Ng, K., et al. 1996). These have been shown to
act on nascent LPG after synthesis of the primary glycan chain, as L. donovani LPG is
used as the acceptor in the in vitro assays. A family of 14 genes from L. major have been
identified, and only a number of these will be active when transferred into L. donovani
(Dobson, D.E., Scholtes, L.D., et al. 2003). L. major has an additional
arabinosyltransferase for side chain synthesis (Dobson, D.E., et al. 2003a;Goswami, M.,
et al. 2006) to add arabinosyl caps to the side chains as they proceed to stationary phase.
In non-permissive vectors, the addition of this arabinose allows for the release of the
parasite for galectins in the insect gut to continue infection. The regulation of both of
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these are critical. L. donovani (Indian isolate) also produces type II LPGs, containing one
or two β-linked glucoses added to the C-3 of the galactose (Mahoney, A.B., et al. 1999).
These are developmentally regulated, as it has been shown that the activity and presence
of glucose is downregulated in the progression to stationary phase, and affects the
binding of the parasite to the midgut of the sand-fly.
7. lpg- mutants, their selection and complementation
The L. donovani genome was only recently sequenced and many difficulties were
encountered attempting to create knockout parasites due to the life cycle (Gueiros-Filho,
F.J. and Beverley, S.M. 1997), thus identification of genes in the lipophosphoglycan
biosynthesis pathway was accomplished using mutagenesis (Figure 1.5). Parasites were
harvested and incubated with N-methyl-N-nitroso-N’nitroguanidine (MNNG)
(Iovannisci, D.M. and Ullman, B. 1984;King, D.L. and Turco, S.J. 1988). Mutants were
then selected for using RCA 120, ricin agglutinin, which recognizes terminal β-galactosyl
residues. The parasites were subjected to multiple rounds of selection with ricin, and
isolated as single cells. Parasites not bound by ricin agglutinin were assumed to be
deficient in LPG synthesis, or lpg-. Structural and enzymatic analysis of these mutants
was performed to determine their suspected defect. A suitable cosmid was developed a
30kB extrachromosomal vector containing a selectable marker termed cLHYG for
transformation of Leishmania parasites via electroporation (Ryan, K.A., et al. 1993a).
Cosmid libraries could be placed into this vector, which holds approximately 40kbp of
DNA, allowing for the entire genome to be screened using only 1000 cosmids total.
Hygromycin was used to select for parasites that contained the cosmid and mutants that
had corrected LPG structures could then be selected. The cosmids are then removed and
shuttled back into E. coli for propagation and screening for open reading frames. Later
variations allowed for creations of single knock out mutants and add backs in L. major
after manipulation of the mutations in the L. donovani.
R2D2 was the first of the mutants selected after mutagenesis with MNNG to be
studied. The structure of the LPG was found to terminate just prior to the addition of the
galactosylfuranose to the core. The parasites still survived in macrophages, did not
produce any full-length LPG (King, D.L. and Turco, S.J. 1988). Further studies of these
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parasites identified LPG1, a galactosylfurasyltransferase unique to the parasites (Huang,
C. and Turco, S.J. 1993;Ryan, K.A., et al. 1993b).
C3PO was the second mutant studied. C3PO lacked the addition of any repeating
units to the core. Complementation identified LPG2, a GDP-Mannose transporter
(Descoteaux, A., et al. 1995;Ma, D., et al. 1997). While initial studies suggested LPG2
might be a single subunit of the GDP-Man transporter, further studies established that the
GDP-Mannose transporter was a hexameric complex of LPG2 subunits capable of not
only transferring GDP-Mannose into the golgi complex, but capable of transferring GDPArabinose and GDP-Fucose as well (Hong, K., et al. 2000). This was a critical
identification, as C3PO was not deficient in N-glycosylation, but only in LPG synthesis.
While LPG2 was found in L. donovani, other strains of Leishmania can incorporate
fucose and arabinose into their LPG.
OB1 was the third mutant characterized. The structure of OB1 LPG consisted of
only the first half of a repeat unit, Man(1)-PO4 attached to the core. Complementation
identified OB1 to be defective in LPG3, a homolog to the mammalian chaperone GRP94
(Descoteaux, A., et al. 2002). Like GRP94, it localized to the endoplasmic reticulum, but
unlike anything known to have a function with mammalian GRP94, it showed a defect in
production of all glycoconjugates, particularly that of LPG and GPI-anchored proteins.
There were no growth defects, but unlike anything seen with a mammalian chaperone,
GRP94 mRNA was developmentally regulated, but not regulated through heat or stress.
LPG3 might be a GRP94 homolog, but has a completely unique function compared to its
mammalian counterpart.
JEDI was the mutant with the last gene characterized. While originally JEDI had
been selected by using ricin, it became quickly obvious that JEDI ended in a terminal
galactose. JEDI has a single complete repeating unit added to the core, but not any others,
and thus further studies with JEDI used CA7AE, an antibody that recognizes the LPG
repeating unit to further purify JEDI out of any potential revertants prior to analysis
(Descoteaux, A., et al. 1998). JEDI was complemented using LPG4A, and was the first
mutant to concretely establish that the iMPT and eMPT activities were in fact discrete
entities. LPG4A complementation of JEDI lead to a further understanding of the genes in
the context of MPT activities. Further analysis of JEDI identified that it wasn’t just
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defective in one gene, but it was defective in another later to be identified as LPG4C.
LPG4A and LPG4C were located on the chromosome next to each other, and are fused
together.
8. Current studies on LPG4A, LPG4B, and LPG4C
LPG4A, LPG4B, and LPG4C have since been individually knocked out in L.
major. Work on these mutants has shown LPG4A to have no defects in LPG synthesis,
but defects in other phosphoglycans. LPG4C produces LPG similar to JEDI, and LPG4B
can not add the first repeating unit to the core. Enzymatic analysis show LPG4B is most
likely the iMPT, as iMPT activity using stachyose as the acceptor is completely
obliterated in that mutant. Surprisingly, LPG4A and LPG4C knockouts, while retaining
iMPT activity, show a marked decrease in iMPT activity. These mutants show no
difference in the galactosyltransferase activity, suggesting this is likely do to the absence
of each of these individual enzymes suspected to be in a complex. LPG4C knockouts
have an absence of eMPT activity, while there is no obvious change in eMPT activity in
LPG4A knockout. All of these are consistent with their suspected functions based on
their structures. A mutant lacking LPG4C but with an additional copy of LPG4A rescues
LPG synthesis based on LPG structure (Beverley et.al, personal communication), similar
to the rescuing of JEDI by LPG4A alone, even though LPG4A is not outright involved in
LPG synthesis. A summary of all mutants is found in Table 1.1.
9. Overview of Dissertation
The repeating units of Leishmania LPG are a structural motif not found in
humans. The number of repeating units on LPG is highly regulated and controlled, and is
critical to the parasites life cycle, critical to the infectivity of the parasite, and can alter
the innate immune response. The importance and uniqueness of the repeating units makes
them a key chemotherapeutic target, and stresses the importance on the understanding of
the biosynthesis of LPG.
There are a number of critical enzymes in LPG biosynthesis, but MPTs are key as
they add the unique Man(α1)-PO4. There are 3 MPTs minimum to the formation of LPG,
an initiating, an elongating, and a serine-specific. Another key regulator in the life cycle
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are the side chain glycosyltransferases which can affect vector specificity and immune
response.
Mutagenized parasites and their functional rescue have been key to understanding
LPG biosynthesis, and the mutants themselves are critical to understanding the structural
formation LPG takes while on the cell surface to cause ricin resistance. JABBA, a
parasite selected for resistance to ricin after mutagenesis with MNNG, in preliminary
LPG analysis showed an increase in the number of repeating units in logarithmic phase
and an increase in cap isoforms. This dissertation aims to full characterize the LPG,
analyze the enzymes responsible for these changes, and examine the causes of ricin
resistance. The central hypothesis is an upregulation of key enzymes resulting in the
increase in repeating units and additional cap isoforms, and that addition of repeating
units affects ricin resistance.
JABBA shows two key differences in the structure of LPG from wild-type; the
number of repeating units and the cap structures. Wild-type L. donovani (Sudanese) has
15 repeating units in logarithmic phase, and 30 repeating units in stationary phase, while
JABBA LPG has 30 repeating units in logarithmic phase, and 47 in stationary phase, with
a quantifiable length shift in mid-logarithmic phase. JABBA LPG has 3 unique cap
structures found only in logarithmic phase: Glc(β1,2)Man, Gal(β1,4)[Glcβ1,2]Man, and
Gal(β1,4)[Glcβ1,2Manα1,2]Man.
The potential enzymes causing these changes, including the iMPT, eMPT, and βglucosyltransferase were investigated. JABBA had no change from wild-type in iMPT
activity, but showed a doubling in both eMPT and β-glucosyltransferase activity. Product
characterization of the β-glucosyltransferase activity of both JABBA and wild-type
parasites revealed a Gal(β1,4)[βGlc]Man product on L. donovani LPG in both parasites,
resembling the structure of the unique trisaccharide cap in JABBA parasites. Wild-type
has no in vivo activity, but this reveals the presence of a post-translationally regulated
glucosyltransferase that differs from the L. donovani (Indian isolate) βglucosyltransferase.
While terminating in galactose, the LPG was still ricin resistance. Logarithmic
and stationary phase parasites were checked for agglutination by ricin, peanut agglutinin,
and concanavalin A and susceptibility to galactose oxidase. While parasites in all phases
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showed increased resistance compared to their wild-type counterparts, stationary phase
parasites showed the greatest resistance, showing the number of repeating units was
causing the cap to go cryptic, masking the terminal galactose. This work furthers
previous research in this area, as the caps are most likely to be inaccessible are in
parasites with LPG longer than 30 repeating units.
The work in this dissertation furthers the studies on regulation of the biosynthesis
of Leishmania LPG. Regulation of the eMPTs is critical to developing
chemotherapeutics, and JABBA may hold the key to understanding the differences
between Sudanese and Indian isolates of L. donovani. Overall, JABBA allows for a
unique view into the parasites life cycle not seen previously.
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Table 1.1. Summary of mutants and their identified gene mutations.
Mutant

LPG Structure

Gene

Mutation

Function

R2D2

Man-Man-GlcN-PI

LPG1

Point

Galf Transferase

C3PO

Core-PI

LPG2

Deletion

GDP-Man Transporter

OB1

Man-PO4-Core-PI

LPG3

Point

Chaperone

JEDI

Gal-Man-PO4-Core-PI

LPG4A

Deletion

-

LPG4A-/-

No Change

-

K.O.

PPG eMPT

LPG4B-/-

Core-PI

-

K.O.

iMPT

LPG4C-/-

Gal-Man-PO4-Core-PI

-

K.O.

eMPT
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Figure 1.1. Life cycle of Leishmania species: adopted from (Bray, A. 1999)
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Figure 1.2 Structures of the Leishmania glycocalyx. Large circles represent proteins,
small clear circles represent phosphoglycans. The triangles are caps, and the rectangles
represent a conserved glycan core attached to the representative phospholipid.
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Figure 1.3. The LPG structures of a number of Leishmania species (Bray, A. 1999).
a. (Turco, S.J., et al. 1987) b. (McConville, M.J., et al. 1990) c. (Ilg, T., et al. 1992) d.
(McConville, M.J., et al. 1995)
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Figure 1.4. The reactions to synthesize the major carbohydrate component of LPG.
These reactions take place in the golgi apparatus. The eMPT and GalT trade off until the
molecule is complete. Some species, such as the Indian strain of L. donovani have an
addition of side chains, which are believed to be added after the repeating units are added
to the molecule. iMPT: initiating mannosylphosphoryltransferase, eMPT: elongating
mannosylphosphoryltransferase, GalT: galactosyltransferase, β-GlcT: βglucosyltransferase
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Figure 1.5 A diagram representing the methodology for mutagenesis of parasites
and identify those deficient in LPG synthesis.
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Chapter II
Materials and Methods
1. Materials and Equipment
A. Materials
Chemicals and reagents were obtained as follows: Bacto- Brain Heart Infusion.
(Difco). Alkaline Phosphatase (E.coli), Beta-glucosidase (Almond), Beta-galactosidase
(E.coli) , Alpha Mannosidase (Jack Bean), ANTS (8-Aminonaphthalene-1,3,6-trisulfonic
acid) from Sigma , feta bovine serum (Atlanta Biologicals), APTS (8-aminopyrene-1,3,6trisulfonate) labeling and capillary electrophoresis columns (Ab-Sciex), C-18 Sep-Pak
columns (Waters), BCA Reagent Kit (Pierce), and Protease Inhibitor (Roche).
B. Equipment
Centrifuges: Heraeus Biofuge Pico, Sorvall RC-5B, Sorvall M120-SE ultra.
Incubators: Fisher Brand, Low Temperature Incubator (small scale), New Brunswick
Scientific C-25 shaking incubator. Evaporator: Savant SpeedVac Plus, Organomation
Nitrogen Evaporator, N-EVAP#112. Capillary Electrophoresis: Beckman P/ACE MDQ
2. Parasites and Mutagenesis
A. Parasites
L. donovani (MHOM/SD/00/1S-2D) , L. donovani (MHOM/IN/83/Mongi-142),
and JABBA were maintained in M199 with 10% FBS as described previously (Kapler,
G.M., et al. 1990).
B. Mutagenesis
Parasites were selected and mutagenized as described previously (King, D.L. and
Turco, S.J. 1988). The cell concentrations used in ricin selection were between 2 x 106
and 2 x 107 cells/ml.
3. Purification and analysis of LPG
A. Purification of LPG
Logarithmic phase JABBA promastigotes were extracted at 5.0 x 105 to 1.0x 106
parasites per milliliter from brain heart infusion supplemented with heme and adenosine
(Orlandi, P.A., Jr. and Turco, S.J. 1987). LD4 and Mongi were extracted at 3.0 x 106 to
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6.0 x 106 parasites per milliliter for logarithmic phase. All strains were extracted at
greater than 2.0 x 107 parasites per milliliter for stationary phase.
Logarithmic parasites were extracted using the Ferguson method as detailed
previously (Proudfoot, L., et al. 1996) using two 2 mL 4 h washes in
methanol/chloroform/water (2:1:0.8) to remove various glycolipids followed by two 0.5
mL washes in 9% 1-butanol collected after 30 min of water bath sonication. Purification
of these fractions on octyl-sepharose chromatography, using a 60% propanol gradient.
Fractions were spotted on silica thin layer chromatography plates and sprayed with
orcinol and sulfuric acid and subsequently charred in a 100°C oven for approximately 8
min to identify the LPG containing fractions.
Stationary parasites were extracted by the Folch method (McConville, M.J., et al.
1990;Orlandi, P.A., Jr. and Turco, S.J. 1987). After centrifugation, pellets were washed
twice with PBS, twice with chloroform/methanol/water (3:2:1), three times with 4 mM
MgCl2 and three times with solvent E (water/ethanol/diethylether/pyridine/NH4OH,
15:15:5:1:0.017) to purify and collect LPG, then dried under N2. Dried material was
resuspended in 0.1 N acetic acid/ 0.1 N NaCl (running buffer) and purified using phenylsepharose chromatography. The column was equilibrated with 6 column volumes running
buffer, then crude LPG was applied. The column was then rinsed with 6 column volumes
running buffer, 4 column volumes 0.1 N acetic acid and 1 column volume water. The
LPG was eluted with 6 column volumes solvent E and dried under a stream of N2.
B. Mild Acid Hydrolysis
Dried LPG was resuspended in 150 µL 0.02 N HCl and incubated at 60ºC for 15
min. After the mixture was dried under a stream of N2, 150 µL toluene was added and
evaporated three times. This treatment cleaves at the phosphate of the repeating units.
C. Butanol Partition and C18 lipid removal
To remove the core-lipid from samples treated with mild acid hydrolysis, dried
samples were treated with water-saturated 1-butanol (McConville, M.J., et al. 1987). The
top (organic layer) was removed and set aside for further analyses of the core and lipid.
The aqueous layer was dried for anionic chromatography to collect caps and repeats. If
the lipid was not being saved, the aqueous sample could be applied to a C18 sep-pak
column and carbohydrate collected with water.
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D. Nitrous Deamination
To separate the lipid from carbohydrate, purified core-lipid or whole LPG was
dried and resuspended in 300 µL 0.25 M sodium acetate (pH 4.0) and 300 µL 0.5 M
sodium nitrite (Ferguson, M.A., et al. 1985). The mixture was left in a water bath for 16 h
at 37ºC.
E. Strong Acid Hydrolysis
To cleave between the glycosidic bonds, oligosaccharides were treated at 100ºC
for 3 h with 2 N trifluoroacetic acid. After this treatment, desalting is required (see
section G).
F. Enzymatic Treatments
Alkaline phosphatase treatment was performed using 1U in 1 mM Tris-HCl (pH
9) overnight at 37°C. β-glucosidase treatment was performed overnight using 1U in 200
mM ammonium acetate at 37°C. α-mannosidase treatment was performed overnight
using 0.1 M sodium acetate pH 4.5 with 1 U at 37°C. β-galactosidase treatment was
performed overnight with 1U in sodium phosphate buffer at 37ºC.
G. Desalting and Anionic Exchange Chromatography
Desalting was performed with a mixed bed of equal parts AG-50WX10 and AG1X8. For most small samples, a total column volume of 0.5 mL was used. For desalting
prior to capillary electrophoresis, a 1 mL mixed bed column was used. For anionic
exchange chromatography, a 1 mL bed of AG1-X8 was used and samples were applied
and allowed to sit for ten min. 6 mL of water was used to collect caps, then 6 mL of 0.3
M NaCl was used to collect repeats from samples.
H. Stains-All
Approximately 20 µg of LPG was run for 1 h at 120 V on 12% SDS-PAGE. The
gel was rinsed three times for 10 min in 25% isopropanol and left immersed for
approximately 16 h. The isopropanol was poured off, and the gel was incubated in stainsall solution (64.5% water, 25% isopropanol, 5% foramide, 5% stains-all, 1% water) for 2
h (Bahr, V., et al. 1993). The gel was destained in 40% ethanol until visualization.
I. Fluorophore Assisted Carbohydrate Electrophoresis.
Oligosaccharide fluorophore assisted carbohydrate electrophoresis was used
following the method of Lehrman and Gao and the subsequent modifications (Gao, N., et
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al. 2013;Lehrman, M.A. and Gao, N. 2003). The resolving gel stock was 38%
acrylamide/ 2% bis-acrylamide with a buffer of 1.5 M tris-chloride (pH 8.9). The
stacking gel was 10% acrylamide, 2.5% bisacrylamide, with a buffer of 1.0 M trischloride (pH 6.8). Samples were labeled with 0.15 M ANTS in 15% acetic acid and 1 M
sodium cyanoborohydride in DMSO overnight at 37ºC. The gel was run at 20 mAmps
and 4ºC for approximately 3 h until it reached the bottom. A glucose standard ladder of
oligosaccharides was used.
J. Separation of Monosaccharides via Capillary Electrophoresis
Samples were labeled using 2 µL monosaccharide APTS and 2 µL 1M sodium
cyanoborohydrirde in THF for 90 min at 55°C. Before loading into the unit, 196 µL of
water was added to the samples. The capillary was conditioned for 2 min with 0.1 N
NaOH and then 0.1 N HCl with a 1 min water rinse between. The capillary was coated
for 2 min with a running buffer of 30 mM sodium borate with 5% methanol. Samples
were injected at a rate of 0.4 psi for 4 sec, and voltage separated for 20 min. Standard
curves of anhydromannose, created by nitrously deaminating glucosamine, and mannose
were used for quantification. The sensitivity ratio between mannose and anhydromannose
was found to be 1.5 to 1, consistent with previous results (Barron, T.L. and Turco, S.J.
2006). Galactose and glucose are roughly equal to mannose in sensitivities.
K. Separation of Oligosaccharides via Capillary Electrophoresis
Neutral desalted oligosaccharides were run through a carbohydrate coated silica
column. They were labeled overnight using oligosaccharide APTS containing acetic acid
and sodium cyanoborohydride in the dark at room temperature. The capillary was
conditioned using 10 min rinse of water at 30 psi followed by a 10 min 30 psi rinse of
carbohydrate buffer. The column was coated with gel buffer for 5 min at 20 psi before
applying samples. The ladder was injected for 0.4 sec at 0.4 psi and separated at a
maximum of -25 kV for 20 min with reverse polarity. For product characterization of the
glucosyltransferase assay, the sample injection rate was 5 psi for 5 sec. For every other
visualization, 0.4 psi for 4 sec was used. (Soares, R.P.P., et al. 2004)
L. Partially Methylated Alditol Acetates
The structure of the cap isoforms was determined using partially methylated
alditol acetates, adapted from the previously published protocol (Pettolino, F.A., et al.
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2012). Material was dried in a speed vacuum concentrator then resuspended in methanol
and evaporated twice. 50 µL of DMSO was applied to the sample in a screw top tube and
placed in a sonicating water bath for 30 min. Approximately 50 µL of slurry of NaOH in
DMSO was applied via capillary pipette to the sample and sonicated again for 30 min in
the water bath. Three applications of iodomethane were applied with two 10 µL, 10 min,
sonication applications and a 20 µL, 20 min, application. The methylated product was
extracted using dichloromethane and water. The dichloromethane soluble portion was
dried and resuspended in 250 µL 2 N TFA in a 100ºC oven for 90 min. The sample was
dried and resuspended in 50 µL 2 M ammonium hydroxide. A 1 M solution of sodium
borodeutride in 2 M ammonium hydroxide was freshly prepared and 50 µL applied to the
sample and allowed to incubate at room temperature for 2.5 h. The samples were then
evaporated with methanol in 5% acetic acid twice, followed by two rinses of methanol.
250 µL of acetic anhydride was applied to the samples in a 100ºC oven for 2.5 h. After
removal from the oven, the sample was allowed to cool and 2 mL of water was added.
The samples were then extracted with 1mL of dichloromethane and cleaned with 2 mL of
water twice. The dichloromethane was then collected and dried under a stream of N2
carefully. The sample was resuspended in an appropriate amount of dichloromethane and
sent to the UK Mass Spectrometry facility for analysis via gas chromatography-mass
spectrometry.
The GC-MS was performed by the UK Mass Spectrometry facility on a Shimadzu
GCMS-QP5000 (quadrupole mass spectrometer) equipped with a GC-17A gas
chromatograph. Electron ionization (EI) mass spectra were recorded at 70eV, scanning
m/z 45-550 at ~1 scan/sec. The GC column was a DB-5ms (Agilent/J&W) 30m x
0.25mm (0.25 um df) with helium as the carrier gas. The column oven temperature
program was 50°C (1 min initial hold) to 280°C at 10°C/min, with an injector temperature
of 250°C and an interface temperature of 280°C.
M. Lipid Analysis
For purification of the lipid for thin layer chromatography, whole LPG was
treated with mild acid. A butanol partition was then performed collecting the butanol and
drying it under a stream of N2. Collected product was nitrously deaminated to cleave the
lipid overnight at 37ºC. Product was subject to another butanol partition, dried, then
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resuspended in 0.1N HAc/NaCl and purified via phenyl sepharose chromatography,
collecting the final solvent E fraction. Thin layer chromatography of the nitrously
deaminated lipid was performed as described previously using silica gel 60 TLC plates
and developing with CHCl3: CH3OH: 4.2 N NH4OH (9:7:2) system. Additional controls
used on the plate included phosphatidylinositol, phosphatidylcholine, and previously
purified alkyl-lyso-phosphatidylinositol in addition to L. donovani and JABBA purified
lipids. (Mahoney, A.B., et al. 1999;Orlandi, P.A., Jr. and Turco, S.J. 1987).
4. Enzymatic Assays
A. Preparation of Microsomal Membranes.
Microsomal membranes were prepared as previously described (Mengeling, B.J.,
et al. 1997b), with the following modifications: Cultures of parasites (200 m) were
centrifuged at 2700 rpm for 7 min, and resuspended in 10 mL of lysis buffer containing
100 mMol HEPES (pH 7.4), 50 mMol KCl, 1 mMol EDTA (pH 8.0), 10% glycerol, and
protease inhibitor. The suspension was subjected to nitrogen cavitation using a Parr
bomb for 30 min at 1500 psi on ice. Subsequent centrifugations took place at 4°C for
3000 x g, 10000 x g for 10 min, and 100000 x g for 1 h. The supernatant was removed,
and the pellet was resuspended in membrane buffer containing 100 mMol HEPES (pH
7.4), 50 mMol KCl, 1 mMol TLCK, and 1 µg/ml leupeptin using a homogenizer. The
final protein concentration was determined with a BCA reagent kit.
B. Initiating Mannosylphosphoryltransferase (iMPT) Assay
The iMPT in vitro assay was performed as previously reported (Mengeling, B.J.,
et al. 1997b) with the following modifications. The assay mixture contained 1 mg
membrane protein, 15% glycerol, 2.5 mMol thioglycerol, 10 mMol MnCl2, 5 mMol
MgCl2, 4 mMol dithiothreitol, 800 µMol GDP-Man, and 27 nCi per4 mMol stachyose in
100 µL. The mixture was incubated for 4 h at 30°C and the reaction was terminated on
ice. Product purification was performed as previously detailed (Mengeling, B.J., et al.
1997b) and radioactivity was counted via scintillation.
C. Elongating Mannosylphosphoryltransferase (eMPT) Assay
The eMPT assay involved the preparation of soluble proteins from the
microsomal preparations. These soluble microsomal proteins were prepared with final
concentrations of 50 mMol HEPES (pH 7.5), 150 mMol KCl, 10 mMol MnCl2, 5 mMol
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MgCl2, 20% glycerol, 1 µg/ml leupeptin, and 0.5% dodecyl-maltoside and 3 mg of
microsomes. The microsomal mixture was rotated for 1 h at 4°C and then centrifuged at
100,000 x g for 1 h. The supernatant collected was used for the eMPT assay.
The eMPT activity was quantified as done previously (Carver, M.A. and Turco,
S.J. 1991) with the following modifications using an assay mixture of 1 mMol ATP, 0.5
mMol dithiothreitol, 2 mMol GDP, 10 mMol MnCl2, 5mMol MgCl2, 225 nCi of [3H]GDP-Man at 200 µMol and 75 µL solubilized microsomal protein in a total of 150 µL.
An exogenous acceptor (25 µg) of JEDI LPG (Descoteaux, A., et al. 1998), possessing a
single Gal-Man-PO4 repeat on the glycan core-PI, was used. The assay mixture was
incubated for 1 h at 28°C. The reaction was terminated with 0.5 M EDTA and the
radioactive product was purified via chromatography on phenyl-sepharose and product
containing fractions were determined by scintillation counting.
D. β -Glucosyltransferase Assay
The glucosyltransferase assay was quantified using 0.5 µCi of 34 µMol UDP-Glc
in the same final volume as previously described(Mahoney, A.B. and Turco, S.J. 1999).
LPG was extracted, and total radioactivity was counted via scintillation.
E. Product Characterization of β -Glucosyltransferase Assay
For product identification, the product from nonradioactive β-glucosyltransferase
assays, along with assays lacking UDP-Glc and exogenous LPG were desalted on a
mixed bed column (2 mL) of AG-50W and AG1-X8 then dried. One aliquot of the
product was treated with mild acid as described previously, then desalted. Another
aliquot was treated with mild acid hydrolysis and dephosphorylated with alkaline
phosphatase, then desalted. The samples were then reductively labeled overnight with
APTS and sodium cyanoborohydride in THF in the dark at room temperature. Product
obtained after mild acid and alkaline phosphatase was also analyzed by exoglycosidase
treatments. For analysis by oligosaccharide capillary electrophoresis, injection pressures
were 5 psi for 5 sec (Soares, R.P., et al. 2004) unless otherwise stated.
5. Resistance Assays
A. Lectin Assays
For 30 min, 5.0x106 cells were rocked in 5 mL of M199 containing 100 µg of
peanut agglutinin, RCA 120 (ricin agglutinin), or concanavalin A. 10 µL of cells were
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placed on a hemacytometer and free cells were counted. The parasites were selected in
logarithmic phase at a culture density of less than 1.0 x 106 cells and in stationary phase
at a minimum of 1.0 x 107 cells.
B. Galactose Oxidase Treatment.
1.0 x 109 logarithmic and stationary cells from L. donovani and JABBA were
treated with 3U galactose oxidase in 500 µL PBS at 25°C for 1 h (Sacks, D.L., et al.
1995). LPG was collected and purified using the Folch method. Caps were isolated after
mild acid hydrolysis, butanol partition, and separation of AG1X-2 using the charge, then
dried in a speed vacuum concentrator. Caps were then treated with 2 N TFA in a 100°C
oven for 3 h, and desalted as described above. The caps were dried and labeled as
described for monosaccharide capillary electrophoresis. A 75 µM bare fused silica
capillary was run at 20 kV using a 15 mM sodium borate, 2.5% methanol buffer for 10
min. The percent of galactose available for reaction with galactose oxidase was
calculated using caps collected in the same fashion, and normalizing to the areas of
mannose. The percentage galactose available was calculated as the total area of galactose
found in galactose-oxidase treated cells to those that were not.
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Chapter III
The Structure of the Lipophosphoglycan of JABBA parasites
1. Introduction
Leishmania parasites have a unique life cycle that requires an extensive
glycocalyx for protection from the sand-fly gut, complement in the bloodstream, and the
mammalian phagolysosome (Kaye, P. and Scott, P. 2011). Lipophosphoglycan, one
component of the Leishmania’s glycocalyx, is critically regulated throughout this life
cycle as it progresses from procyclic promastigote through metacyclic promastigote to
amastigote (de Assis, R.R., et al. 2012). Lipophosphoglycan is the dominant glycocalyx
molecule in the promastigote stage, and most frequently studied there.
The Leishmania genome has only recently been sequenced (Ivens, A.C., et al.
2005), so earlier attempts to identify genes involved in biosynthesis of LPG involved
chemical mutagenesis of parasites by MNNG and selection by ricin exposure to identify
mutants defective in LPG (Iovannisci, D.M. and Ullman, B. 1984;King, D.L. and Turco,
S.J. 1988). Critical mutants selected have been defective in LPG synthesis and identified
four genes (Descoteaux, A., et al. 2002;Descoteaux, A., et al. 1998;Hong, K., et al.
2000;Ma, D., et al. 1997;Ryan, K.A., et al. 1993b): LPG1, a
galactosylfuranosyltransferase, LPG2, the GDP-Mannose transporter, LPG3, a heat
shock protein chaperone, and LPG4A, a mannosylphosphoryltransferase. LPG4B and
LPG4C were also identified from studies with these mutants (Beverley, personal
communications). JABBA is the first extensively studied ricin resistance parasite not
defective in LPG synthesis, and is critical to determining the complete structure of LPG
and how it differs from wild-type.
Early data suggests that the structure of the parasites have abnormal cap isoforms,
most likely with the addition of a β-glucose reminiscent of the β-glucose containing LPG
of the Indian strain of L. donovani. The increase in repeating units, while not having been
quantified, suggests the parasite may be “stuck” in metacyclogenesis, and will not
necessarily elongate in once in stationary phase. The nature of these hypotheses will be
discussed alongside the complete structure.
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2. Results
The structure of lipophosphoglycan consists of a conserved core and unique 1-Olyso-alkyl-phosphatidylinositol, a stage specific number of Gal(β1,4)Man(α1)-PO4
repeating units, and a terminal cap. LPG in wild-type L. donovani Sudan (LD4) averages
15 unsubstituted repeating units in logarithmic phase and 30 unsubstituted repeating units
in stationary phase (Barron, T.L. and Turco, S.J. 2006), while the terminal cap structure
can vary from a single terminal mannose to a full repeating unit, occasionally with an
additional α-mannose (Greis, K.D., et al. 1992). A schematic of L. donovani LPG is
found in Figure 3.1.
A. JABBA produces a much larger LPG than wild-type.
JABBA was selected for being ricin-resistant after mutagenesis with MNNG. Most
parasites selected through this technique produce much shorter LPG than wild-type.
Initial quantification of total LPG estimates that JABBA produces approximately 1/3rd
the LPG of L. donovani (LD4). Through visualization by stains-all on a 12% SDS gel,
logarithmic phase JABBA was found to produced LPG roughly twice the size of wildtype, similar in size to LPG in stationary wild-type. Surprisingly, in JABBA stationary
phase LPG appears to increase in size relative to logarithmic phase. (Figure 3.2)
B. The structure and number of the repeating units of JABBA LPG
An increase in the size of LPG is due to either the number of repeating units or
the addition of side chains to the repeating units. Using fluorophore assisted
carbohydrate electrophoresis to visualize the repeating units, L. donovani was shown to
contain a disaccharide as expected, as did JABBA (Figure 3.3). The purified
disaccharides were treated with strong acid hydrolysis and the individual components
were verified to be galactose and mannose in both L. donovani and JABBA by
monosaccharide capillary electrophoresis. (Figure 3.4)
After verifying that the composition of JABBA’s repeating units is the same as L.
donovani’s, it was neccessary to determine the number of repeating units present. In
order to quantify the repeating units using monosaccharide capillary electrophoresis, the
fluorescence ratio of anhydromannose to mannose was found to be 1.5 to 1 as previously
published (Barron, T.L. and Turco, S.J. 2006). Standard curves were used to determine
the total amounts of anhydromannose and mannose in a sample. An example of the CE
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chromatogram found from analyses to determine the repeating units is found in Figure
3.5. The number of L. donovani repeating units was determined to be 15 in logarithmic
phase and 30 in stationary phase, matching previously published data (Sacks, D.L., et al.
1995). Logarithmic phase JABBA LPG has 30 repeating units, 47 in stationary phase.
Over the course of data collection, a mid-logarithmic LPG size was found to be 42.
(Table 3.1)
C. The structure of the caps of JABBA Lipophosphoglycan
As JABBA LPG structure is larger than wild-type, it was critical to establish if the
caps contained a galactose. In other mutants, ricin-resistance was confered by shorter
LPG structures that without a terminal galactose (Descoteaux, A., et al. 2002;Huang, C.
and Turco, S.J. 1993). Using fluorophore assisted carbohydrate electrophoresis, the cap
structures of the L. donovani and JABBA were compared. L. donovani showed a
disaccharide and monosaccharide, with a faint trisaccharide, reminiscent of the published
cap structures of L. donovani (Greis, K.D., et al. 1992). JABBA showed the same 3
bands, plus an additional trisaccharide and tetrasaccharide (Figure 3.6).
As FACE gels require large quantities of materialto visualize JABBA caps,
oligosaccharide capillary electrophoresis was used to view the enzymaticly reacted cap
structures due to its sensitivity. In L. donovani caps, one disaccharide was β-galactosidase
sensitive, while the other disaccharide was α-mannosidase sensitive; the trisaccharide was
sensitive to both. No L. donovani caps were β-glucosidase sensitive. This matches
previously published data for L. donovani caps (Greis, K.D., et al. 1992), and the exact
linkages were not pursued further.
Capillary electrophoresis of reacted JABBA caps revealed the presence of two
trisaccharides, one of which aligned with the trisaccharide from L. donovani. The CE
chromatogram of JABBA caps are found in Figure 3.7. These two structures were both βgalactosidase and β-glucosidase sensitive, but α-mannosidase resistant. Parasites
collected at a density greater than 3.0 x 106 parasites/ml lacked both the unique glucosecontaining trisaccharide and tetrasaccharide, matching the wild-type cap profiles.
Monosaccharide capillary electrophoresis was used to calculate the relative ratios
of substituents of bulk cap samples shown in Figure 3.8. The chromatograms are adjusted
to the elution times to view the glucose. Mannose was used for normalization, as every
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cap isoform contains a mannose in both L. donovani and JABBA caps. The comparison
showed a similar amount of galactose in logarithmic cap samples of L. donovani and
JABBA, but stationary JABBA cap samples showed approximately half the amount of
galactose. Equivalent amounts of glucose and galactose were found in JABBA
logarithmic cap samples. Combined with oligosaccharide capillary electrophoresis, the
relative amounts of each cap isoform were calculated in Table 3.2.
These cap structures were predicted to be Gal-(Glc)Man and Gal-(Glc-Man)Man.
It is important to note that after both β-galactosidase and β-glucosidase treatment there
was a decrease in the total amount of disaccharide present in the sample, suggesting there
was a glucose containing disaccharide present. Predicted disaccharide structures include
Man-Man, Gal-Man, and Man-Glc.
Partially methylated alditol acetates were used to determine the linkage as the
composition and order were already known. L. donovani has Gal (β1,4)Man,
Man(α1,2)Man, Man, and Gal(β1,4)[Man(α1,2)]Man caps. Besides a 2,4-linked
mannose, JABBA showed no other hinge mannose, suggesting that the linkage (Figure
3.9) between the glucose and mannose is Glc(β1,2)Man, consistent with type-III LPG.
Approximately 20% of the sample was terminal glucose, verifying the capillary
electrophoresis calculations on total cap isoforms. The unique cap structures found on
JABBA LPG were Glc(β1,2)Man, Gal(β1,4)[Glc(β1,2)]Man and
Gal(β1,4)[Glc(β1,2)Man(α1,2)]Man. The percentages of all structures are found in Table
3.3.
D. Core and Lipid Structure of JABBA LPG
For analysis of the core, both L. donovani and JABBA LPG glycan cores were
separated from the lipid by nitrous deamination. The primary components of each were
identified as galactose, mannose, and anhydromannose (Orlandi, P.A., Jr. and Turco, S.J.
1987;Turco, S.J., et al. 1989). The oligosaccharide analysis showed both as a
hexasacharide. The monosaccharide compotents and oligosaccharide size of both JABBA
and L. donovani matched previously published data.
The lipid was purified on phenyl-sepharose after nitrous deamination. Thin layer
chromatography was performed developing in a chloroform/methanol/ammonium
hydroxide system observing L. donovani and JABBA purified lipids from LPG along
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with standards: phosphatidylinositol, and phosphatidylcholine. The migration times were
consistent with the published data (Orlandi, P.A., Jr. and Turco, S.J. 1987) classifying the
structure of the lipophosphoglycan lipid. TLC plates showed approximately 8.5cm
migration time for the lipid in L. donovani (LD4) and JABBA. Migration times are found
in Table 3.4.
3. Discussion
The structure of LPG throughout the life cycle of the parasite is critically
regulated (Sacks, D.L., et al. 1995). The glycan core and alkyl-lyso-phosphatidylinsoitol
lipid anchor are conserved in the structure (McConville, M.J., et al. 1990;Orlandi, P.A.,
Jr. and Turco, S.J. 1987;Turco, S.J., et al. 1989) and is frequently found as the basis for
other glycolipids on the cell surface. The procyclic promastigote LPG has 15 repeating
units consisting of Gal(β1,4)Man(α1)-P and ends in a terminal cap that can be a mannose,
a full repeating unit, Man(α1,2)Man or a repeating unit substituted with α-mannose on
the mannose of the repeating unit. This is all present on the C-2 of the mannose as LPG.
Metacyclic LPG has approximately 30 repeating units, the increase in units causing the
release from the parasite gut (Sacks, D.L., et al. 1995), and the number of repeating units
effects many functional attributes (Gaur, U., et al. 2009).
Besides the number of repeating units, species of Leishmania that have LPG with
side chains are also developmentally regulated (Coelho-Finamore, J.M., et al. 2011;de
Assis, R.R., et al. 2012;Dobson, D.E., et al. 2003b). While L. donovani Sudan doesn’t
possess any side chains, L. donovani India has β-Glucose substituted on the C-3 of
galactose (Mahoney, A.B., et al. 1999). The percentage of glucose decreases as the
parasite progresses from procyclic to metacyclic form. Other species, like L. major, cap
their side chains with other sugars as they proceed from procyclic to metacylic phase
allowing for release of the parasite from the sand-fly gut (Dobson, D.E., et al.
2010;Dobson, D.E., et al. 2003a).
JABBAs LPG size increase is reminiscent of a parasite that has undergone
metacyclogenesis in logarithmic phase. There is no obvious explanation for why it
continues to stationary phase, contrary to the initial hypothesis that it would not elongate.
The repeating units are the same composition as wild-type and the increase to 30 units in
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logarithmic phase and to 47 in stationary is the primary difference between the strains.
JABBA also shows a mid-logarithmic length of 42, a change that has not been previously
noted in L. donovani. Depending on the assay and the total density of the parasites used,
an increase in the average number of repeating units can be found in cultured logarithmic
phase L. donovani. If this phenomenon is a by-product of culturing the parasite outside of
the sand-fly is unknown. For this reason, we have defined our phases to avoid midlogarithmic length: logarithmic is less than 3.0 x 106 parasites/ mL, stationary is greater
than 1.0 x 107 parasites/mL.
In regards to the cap structure, there is the inclusion of a β-glucose similar to the
Indian strain of L. donovani, but the acceptor has changed. Whether this is a separate
mutation within JABBA, or the result of a novel β-glucosyltransferase inactive in LD4
(Sudanese L. donovani) will be examined later in this work.
The apparent down-regulation of glucose in JABBA cap isoforms is also similar
to L. donovani India, as it decreases the number of glucose side chains present on its
LPG as it progresses from procyclic to metacylic phase, as this decrease is critical for the
release of the parasite from the sand fly gut (Mahoney, A.B., et al. 1999;Mahoney, A.B.
and Turco, S.J. 1999). This makes it the most likely explanation for the origin of the
glucose present on the caps of JABBA, as L. donovani Sudan, the parasite that was
originally mutagenized to create JABBA, does not have an β-glucosyltransferase active
in vivo.
An interesting statistic is the dramatic decrease of galactose in JABBA LPG cap
during the progression from logarithmic phase to stationary phase. Ratios between
mannose, galactose and glucose were calculate in wild-type L. donovani, JABBA
logarithmic caps, and JABBA stationary caps. As mentioned above, there was no glucose
in JABBA stationary caps, which was demonstrated by a change in the isoforms back to
wild-type, no glucose in themonosaccharide analysis, and the caps resistantance to
treatment with β-glucosidase. Looking at the relative ratios of mannose to galactose,
JABBA stationary phase caps contain half the galactose of JABBA logarithmic caps and
wild-type L. donovani. While this would be an abnormal statistic in any normal strain,
this decrease does lead to one hypothesis on the formation of JABBA LPG. In stationary
phase, the parasite is continuing to try to elongate its LPG; it does not have a stopping
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point. In other words, the eMPT is essentially unregulated, the possibility exists that the
glucose is the only regulator, as modification to the terminal-galactose molecule has been
shown to prevent action of the eMPT (Routier, F.H., et al. 2000).
Based on our defined points of logarithmic and stationary phase, the glucosyl
residue is lost at approximately 3.0 x 106 parasite/ml, where we start to see the initial
increase in size. One might believe the glucose is the only reason we see any apparent
regulation of the eMPT in JABBA. The 47 repeating units is likely to be a stopping point
where the parasite is physically unable to continue to elongate any further at this point.
There is also a definite possibility that the parasite can not move LPG beyond that length
to the surface. We know formation of the LPG takes place in the golgi, and moving large
LPG to the surface could cause transport problems.
There are quite a number of questions that still exist in our understanding of
metacyclogenesis. Recently an algorithm was formulated that would allow to show there
is a notable difference in morphology of the parasite once it has undergone
metacyclogenesis (Berg, M., et al. 2013). While not shown here, there is a notable visual
difference between logarithmic phase L. donovani and logarithmic phase JABBA
parasites. The overall behavior of the parasites more closely resembles those of stationary
L. donovani parasites; they have a greater tendency to form rosettes or stick together like
stationary L. donovani. This behavior, combined with the structure of JABBA’s LPG,
suggests further analyses of JABBA could lead to an understanding of the critical
regulatory events that are required for Leishmania species to undergo metacyclogenesis.
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Table 3.1. Average number of repeating units per molecule of LPG in L. donovani
(LD4) and JABBA parasites based on the growth-phase. Logarithmic phase samples
n>8, stationary phase samples n=3 separate LPG preparations for analysis.

Parasite

Growth
Phase

Average
Repeats

Parasite

Growth
Phase

Average
Repeats

P-value

LD4

Logarithmic

15

JABBA

Logarithmic

30

<.0001

Stationary

30

Stationary

47
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Table 3.2: The ratio of mannose to glucose to galactose of cap samples based on
capillary electrophoresis area calculations. The calculations were normalized to
mannose. Note the decrease in galactose found in stationary JABBA LPG caps. Data was
averaged from three separate runs of each sample.
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Table 3.3. Cap isoforms and relative percentages found on JABBA LPG. Calculations
were based on area percentages from capillary electrophoresis and permethylation
experiments

Oligosaccharide Cap Structures

Percentage of total
sample

Disaccharides

50-80%

Gal(β1,4)Man
Man(α1,2)Man
Glc(β1,2)Man

Trisaccharides

Gal(β1,4)[Man(α1,2)]Man

10-46%

Gal(β1,4)[Glc(β1,2)]Man
Tetrasaccharide

Gal(β1,4)[Glc(β1,2)Man(α1,2)]Man
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0-4%

Table 3.4: Thin layer chromatography lipid migration distances. Distances were
measured from the initial spot to the start of the final spot upon completion.

Lipid

Distance Migrated

Phosphatidylinositol

9.5cm

Phosphatidylcholine

10.5cm

LD4 LPG Lipid

8.5cm

Jabba LPG Lipid

8.5cm
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Figure 3.1. Diagram of LPG from LD4 (wild-type) and JABBA LPG. The structure of
the lipid anchor, is 1-O-alkyl-2-phosphatidylinositol. The percentages of the varying cap
isoforms in JABBA are found in Table 3.3.
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Figure 3.2. Representative SDS-PAGE of purified LPG from logarithmic phase and
stationary phase wild-type LD4 and JABBA parasites. Following electrophoresis the gel was
stained with Stains-all solution. Each panel is from a different gel, but representative of the
migratory differences.
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Figure 3.3. Fluorophore assisted carbohydrate electrophoresis of the
dephosphorylated repeat units of LPG. The band from JABBA co-migrating with the
Gal(β1,4)Man disaccharide from wild-type LD4 repeat unit was determined to be
identical based on β-galactosidase digestion and the linkage was confirmed by
methylated alditol acetates by GC-MS.
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Figure 3.4. Monosaccharide capillary electrophoresis of dephosphorylated, strong
acid treated repeat units from LD4 and JABBA. Mannose and galactose are found in
equal proportions in both species, indicative of being found in equal percentage in both
repeating units. Peaks at 11 and 13 min (unlabeled) are artifacts from the core and
glucose.
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Figure 3.5 Representative chromatogram from monosaccharide capillary
electrophoresis for repeating unit quantification. The critical LPG derived peaks are
labeled. Peaks at 11 and 13 min are a core associated artifact and exogenous glucose.
50

Figure 3.6. Fluorphore assisted carbohydrate electrophoresis of LD4 and JABBA
caps collected from the logarithmic stage. LD4 has the standard monosaccharide,
disaccharide, and trisaccharide , while JABBA has the presence of an additional
trisaccharide and tetrasaccharide. The gel front is present just under the G1 marker in all
3 lanes.
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Figure 3.7 Oligosaccharide capillary electrophoresis of caps collected from
logarithmic JABBA LPG. Disaccharides elute at 7 min, trisaccharides elute at 8 min,
and tetrasaccharides elute at approximately 9 min. These bulk samples were treated with
β-galactosidase, β-glucosidase, and α-mannosidase to determine their relative structures.
Gal-Man, Man-Man, and Gal-(Man)Man elution times were similar in LD4. Injection
pressure was 5 psi, 5sec to allow for better visualization of the tetrasaccharide.
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Figure 3.8. Monosaccharide capillary electrophoresis of strong-acid hydrolyzed caps
collected from logarithmic and stationary phase JABBA LPG. There is an absence of
glucose in stationary phase JABBA LPG caps and wild-type LD4 (not shown), compared
to logarithmic phase JABBA LPG caps. Ratios of each sugar are found in Table 3.2.
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Figure 3.9. GC-MS of partially methylated alditol acetates from a bulk sample of
JABBA caps from LPG. GC retention times were determined using Gal(β1,4)Man,
Man, Gal, and Cellobiose standards. 2-Man and 2,4-Man were identified matching wildtype GC retention times and MS spectra. T-Gal: terminal galactose, T-Man: terminal
mannose, T-Glc: terminal glucose, 2-Man: 2-linked mannose, 4-Man: 4-linked mannose,
2,4-Man: 2,4-linked mannose.
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Chapter IV
Characterization of the initiating mannosylphosphoryltransferase, the elongating
mannosylphosphoryltransferase, and β-glucosyltransferase activities of JABBA and
L. donovani
1. Introduction
Many enzymes are responsible for the synthesis of LPG in the parasite. For the
synthesis of the repeating units, an initiating mannosylphosphoryltransferase (iMPT) is
required for addition of the mannose-phosphate (Man-P) to the core (Mengeling, B.J., et
al. 1997b), a galactosyltransferase which adds the galactose to complete the first
repeating unit (Carver, M.A. and Turco, S.J. 1991;Mengeling, B.J., et al. 1997a). An
elongating mannosylphosphoryltransferase (eMPT) adds the next Man-P group, and the
galactosyltransferase adds the next galactosyl unit to complete the second repeating unit
(Descoteaux, A., et al. 1998).
In some Leishmania species and strains, side chains are added to the repeating
units at either the C-3 of the galactose or the C-2 of the mannose residues. L. donovani
Sudanese isolates do not have any side chains on the repeating units, but do have an
additional α-mannose on the C-2 of the cap’s mannosyl unit (Greis, K.D., et al.
1992;Thomas, J.R., et al. 1992). L. donovani Indian isolate has a β-glucosyltransferase
that adds β-glucose to the C-3 of the galactose, and it is subsequently downregulated as
the parasite progresses from logarithmic to stationary phase (Mahoney, A.B., et al.
1999;Mahoney, A.B. and Turco, S.J. 1999). Based on the structural changes in JABBA
LPG, one would expect an increase in the eMPT activity and an increase in βglucosyltransferase activity. The iMPT, eMPT, and β-glucosyltransferase are explored
here as potential causes for the modifications found on the LPG of JABBA, and are
compared to both LD4 (Sudanese L. donovani, wild-type) and Mongi (Indian L.
donovani) for a greater understanding of JABBA in the context of other L. donovani
strains.
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2. Results
The iMPT is required to add the first Man-P to the galactose of the core, with the rate
never expecting to vary, with the exception of the amastigote stage (Mengeling, B.J., et
al. 1997b). Two hypotheses exist to the nature of the eMPT; either there are two that are
stage specific or one that is regulated in an unknown manner (Routier, F.H., et al. 2000).
L. donovani Indian isolate is used as a control for assaying the β-glucosyltransferase
activity. The assays for both the iMPT and eMPT with product characterization are well
documented (Carver, M.A. and Turco, S.J. 1992;Descoteaux, A., et al. 1998;Mengeling,
B.J., et al. 1997b), so the only product characterization included here is that for the βglucosyltransferase. Schematics of reactions produced in each assay are found in Figure
4.1
A. Analysis of the iMPT and eMPT
To account for the increased number of repeating units, there are two critical
enzymes to consider that could cause this increase; the iMPT applying the first Man-P,
and the eMPT applying every subsequent Man-P (Descoteaux, A., et al. 1998). Figure 4.2
shows both iMPT and eMPT activity. The iMPT activity of LD4 (Sudanese L. donovani)
had a rate of 250 pMol mannose-phosphate transferred and JABBA had a rate of 375
pMol mannose-phosphate transferred per milligram protein/h; there was no statistical
difference between the two. The activity of Mongi was no different from LD4 and
JABBA. The eMPT activity was measured using JEDI LPG. LD4 (Sudanese L. donovani
) had 35 pMol mannose-phosphate transferred and JABBA had 70 pMol mannosephosphate transferred per milligram protein/h. The activity of the eMPT in Mongi had not
previously been measured, and was shown to be very close to that of JABBA. Only 3
counts had been taken, so no statistics were calculated using Mongi. While not shown
here, the galactosyltransferase responsible for adding the galactose to the repeating units
was initially surveyed, and no difference was observed.
B. Analysis of the β-Glucosyltransferase
The β-glucosyltransferase assay was adapted from the publication on L donovani
Indian isolate (Mahoney, A.B. and Turco, S.J. 1999) and measures the last reaction found
in Figure 4.1. JABBA showed an activity rate of 9 pMol glucose transferred per
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milligram protein/h, compared to 4 for LD4 ( L. donovani Sudanese isolate) (Figure 4.3).
The Mongi ( L. donovani India )control matched published data. The βglucosyltransferase is well characterized in Mongi ( L. donovani Indian isolate), but has
never been analyzed in LD4 ( L. donovani Sudanese isolate) due to issues with the
methodologies available at that time. To identify the origin of the β-glucosyltransferase in
JABBA, it was critical determine if the apparent activity in vitro in LD4 ( Sudanese L.
donovani) was from the β-glucosyltransferase or was a strict artifact.
C. Partial product characterization of the β-glucosyltransferase assay
Product characterization for the glucosyltransferase from L. donovani Sudan and
JABBA was critical since there is no β-glucosyl chains on the LPG of the Sudanese
isolate of L. donovani; it had been assumed that the activity from Sudanese L. donovani
was an artifact (Mahoney, A.B. and Turco, S.J. 1999). Descending paper chromatography
did not allow for product characterization, as the total radioactivity produced was 1/10th
the amount required, so more sensitive methods were adapted. If measuring βglucosyltransferase activity, a Gal-(Glc)Man or Glc-Gal-Man trisaccharide would be
seen after mild acid hydrolysis alone or with dephosphorylation, if the activity was not
present only a Gal-Man disaccharide would be evident. Capillary electrophoresis allowed
for separation of any trisaccharide product present in the sample from the overwhelming
amount of disaccharide repeating units. A number of conditions had to be met to
determine if any present trisaccharide came from LPG. A trisaccharide was first found in
both L. donovani and JABBA after mild acid hydrolysis and dephosphorylation using
alkaline phosphatase. This suggested the trisaccharide was coming from the repeating
units. Before continuing to analyze the trisaccharide, a number of conditions were tested
that found the trisaccharide to be UDP-Glucose dependent, exogenous LPG dependent,
and mild acid hydrolysis dependent (Data not shown). A small trisaccharide was found
after mild acid treatment alone, suggesting the trisaccharide was also coming from the
caps in addition to the repeats. From this it was concluded that the β-glucosyltransferase
was acting on both the caps and repeating units in vitro in L. donovani and JABBA.
While L. donovani having in vitro β-glucosyltransferase activity explains the
presence of a β-glucose present on the cap of JABBA LPG, it was important to determine
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if the galactosyl or the mannosyl unit was the acceptor for this β-glucose residue in
Sudanese L. donovani. The trisaccharide was subjected to both β-galactosidase and βglucosidase treatment (Figure 4.4) and run on capillary electrophoresis for visualization
to address this question. In both L. donovani and JABBA, the trisaccharide was sensitive
to both treatments: β-glucosidase sensitivity indicates the trisaccharide is formed by the
addition of a β-glucose, β-galactosidase sensitivity indicates a product of Gal-(Glc)Man
instead of Glc-Gal-Man. This was expected in JABBA due to the mannose as the
attachment point for the β-glucose in the caps, but unexpected in L. donovani Sudanese
isolate due to the β-glucosyltransferase adding to the galactose in L. donovani Indian
isolate.

3. Discussion
The techniques to assay and solubilize LPG synthesizing enzymes have existed
for years (Carver, M.A. and Turco, S.J. 1991;Carver, M.A. and Turco, S.J.
1992;Descoteaux, A., et al. 1998;Mengeling, B.J., et al. 1997b)but two of the critical
enzymes have only recently been identified. The LPG4 family consists of 3 enzymes,
LPG4A, LPG4B, and LPG4C which have been identified as a proteophosphoglycanspecific eMPT, the iMPT, and a LPG specific eMPT, respectively (Beverley et. al,
unpublished observations). The eMPTs are related enough that functional rescue of both
L. major knockouts of LPG4C, and the L. donovani mutant JEDI can be accomplished by
complementation with LPG4A. With JABBA being a larger LPG mutant, it would be
difficult to employ traditional techniques to identify the causal mutation.
Regulation of these enzymes is poorly understood, though there is an
understanding that a number of these enzymes are stage specific; particularly those for
side-chains. The glucosyltransferase(s) in the Indian isolate of L. donovani (Mahoney,
A.B. and Turco, S.J. 1999) responsible for the addition of β-glucose side chains show an
80% decrease in activity in the progression from procyclic to metacyclic promastigotes.
The arabinosyltransferase responsible for the capping of the side chains in L. major
functions primarily in metacyclic phase . There are two hypotheses as to the nature of the
regulation of eMPT activity, either one enzyme that is regulated differentially depending
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on the stage, or two enzymes, one that functions during each phase (Routier, F.H., et al.
2000). It has been proposed that a single eMPT should eventually be able to stop
elongating, as it has less affinity for longer structures. The changes in JABBA suggest
that not only is this not the case, there is a similar mode of regulation between the eMPT
and the β-glucosyltransferase, as both are equally upregulated in comparison to wildtype, but the iMPT is regulated in a different manner.
JABBA did have a slight increase in iMPT compared to LD4 and Mongi, which
can be explained by the increase in eMPT activity. When LPG4A or LPG4C is knocked
out, there is a significant decrease in iMPT activity (Beverley et. al, unpublished data). If
these enzymes are working as a complex, or were to have a similar regulatory
mechanism, the increase in eMPT activity could correlate with an increase in iMPT
activity, even if there is less LPG on the cell.
JABBA had twice the eMPT activity and β-glucosyltransferase activity of wildtype LD4, in line with initial hypotheses. Surprisingly, Mongi eMPT activity more
resembled that of JABBA than LD4. This would suggest that the eMPT and the βglucosyltransferase were regulated in the same fashion on some level: whether it be
transcriptional or translational. One could potentially rule out regulatory factors as none
required for activation in Mongi (L. donovani India) (Mahoney, A.B. and Turco, S.J.
1999). As Leishmania genetic regulation is similar to that of bacteria (De Gaudenzi, J.G.,
et al. 2011), one would believe it is more likely due to post-translational regulation.
The β-glucosyltransferase product characterization was critical to understanding
the addition of the glucosyl residue to the caps in JABBA, and identifying potential
mutations to cause this addition. While the product was partially characterized, it should
be noted normal oligosaccharide CE has an injection rate of 0.4 psi for 4 sec, but for
analysis of the trisaccharide 5 psi for 5 sec was required due to such low activity in LD4.
The β-glucosyltransferase in LD4( L. donovani Sudan) and subsequently JABBA
(Figure 4.1, bottom reaction) differs in acceptor specificity from the βglucosyltransferase in Mongi ( L. donovani India )(Figure 4.1, top reaction), but based on
total cap data, appears to be stage-specific similar to the β-glucosyltransferase from
Mongi (L. donovani India). This suggests the two enzymes are related, and the change in
acceptor is likely to be due to drift from the lack of in vivo use in LD4 (L. donovani
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Sudan). As other L. donvani complex species such as L. infantum maintain a β-glucosyl
residue linked to the galactosyl unit, it is unlikely for the shift to have changed from the
mannosyl unit as the acceptor to the galactosyl unit, but through lack of use, the gene
drifted. There is also a possibility another strain of L. donovani exists with a highly active
β-glucosyltransferase attaching attaching a glucosyl residue to the mannosyl residue.
There is a possibility that the β-glucosyltransferase only adds one glucose per
1000 LPG molecules in LD4 in vivo, where it would never be seen from structural
carbohydrate techniques, or acquisition of membranes actually results in activation. The
only conclusive statement that can be made is that there is a β-glucosyltransferase in the
genome of LD4 (L. donovani Sudan) and is transcribed and translated into protein. Based
on the nature of its position in JABBA, it is likely to have a greater preference for
terminal repeating units and the increase in material created by the in vitro assay allowed
for it to add a glucose to the mannose of repeating units.
The base levels of the enzyme are low, and are most likely regulated at the
transcriptional or translational level, while the increase in both the glucosyltransferase
and the eMPT in JABBA suggests they are regulated in the same fashion. As Mongi (L.
donovani India) has an increase in the eMPT activity compared to LD4 (L. donovani
Sudan), one could hypothesize that the mutation in JABBA is activating a key regulatory
difference between the two strains, leading to LPG that in structure and biosynthesis is
more closely related to Mongi (L. donovani India) than the parent LD4 (L. donovani
Sudan). This could be a single regulatory difference, or changes at multiple regulatory
points.
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Figure 4.1. Schematic of the reactions measured in individual enzymatic assays
comparing JABBA and LD4. The Gal(α1,6)Gal linkage in stachyose makes it an
appropriate substrate for the iMPT activity(Mengeling, B.J., et al. 1997b). The β-GlcT
assay was developed for Glc(β1,3)Gal linkage in the Indian isolate of L.
donovani(Mahoney, A.B. and Turco, S.J. 1999), but also allows for measurement of the
Glc(β1,2)Man linkage seen in JABBA LPG caps.
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Figure. 4.2 Comparative iMPT and eMPT activities in microsomal preparations of
wild-type LD4, JABBA, and Mongi. Microsomal preparations from wild-type LD4,
JABBA, and Mongi were assayed for iMPT and eMPT activities as described in
Materials and Methods. Top Panel, iMPT activity, N=3; Bottom Panel, eMPT
activity.N=8 microsomal preparations with the exception of Mongi, N= 3. Error bars
represent standard deviation.
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Figure. 4.3 Comparative β-glucosyltransferase activities in microsomal
preparations of wild-type LD4 , JABBA, and Mongi. Microsomal preparations from
wild-type LD4, JABBA, and Mongi were assayed for β-glucosyltransferase activities as
described in Materials and Methods. N= 8 microsomal preparations for LD4 and
JABBA, 3 for Mongi. Statistics were not calculated for Mongi. Error bars represent
standard deviation.
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Figure 4.4. Partial characterization of the product produced by JABBA βglucosyltransferase assays using whole LPG. Disaccharides run at 7 minutes elution
time; trisaccharides run at 8 minutes. Top Panel: Mild Acid Hydrolyzed,
dephosphorylated product. * Gal-(Glc)Man, **Gal-Man. Middle Panel: β-glucosidase
treated after mild acid hydrolysis and dephosphorylation. ** Gal-Man. Lower Panel: βgalactosidase treated after mild acid hydrolysis and dephosphorylation. *** Glc-Man.
LD4 profiles (not shown) look the same.
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Chapter V
Determining the cause of Ricin Resistance
1. Introduction
Ricin, specifically RCA120, has been used to identify LPG-null Leishmania
mutants (Descoteaux, A., et al. 2002;Descoteaux, A., et al. 1998;King, D.L. and Turco,
S.J. 1988;Ma, D., et al. 1997) for the identification of critical LPG biosynthesis pathways
and genes. Prior to JABBA, the mutants presented were all LPG null, expressing
truncated LPG that often did not terminate in a galactose molecule. As RCA 120 is highly
reactive with terminal β-galactosyl units, more so than other terminal β-galactosyl
binding lectins like peanut agglutinin, these truncated LPG structures clearly explain the
cause of ricin-resistance (Andrade, A.F. and Saraiva, E.M. 1999). JABBA is the first
mutant with large LPG published to date, leaving the resistance to ricin a mystery.
There are two options to explain ricin resistance in JABBA parasites, either the
unique cap structures containing a β-glucosyl residue could block the ability for ricin to
bind to the LPG even if a galactose is present, or the number of repeating units blocks
access to the caps, causing the caps to become “cryptic”. The “cryptic caps” hypothesis
is supported by both nuclear magnetic resonance imaging showing LPG to have a helical
structure and from assays showing that metacyclogenesis and the elongation of LPG
blocks access of lectins to the caps (Homans, S.W., et al. 1992;Sacks, D.L., et al. 1995)
allowing for release from the sand-fly gut. These two hypotheses are modeled in Figure
5.1. Understanding why JABBA is ricin-resistant will help to explain the critical events
required for release of the parasite from the sand-fly gut to continue its life-cycle.
2. Results
Peanut Agglutinin (PNA), Concanavalin A (ConA), and Ricin (RCA 120) are
considered to have equal abilities to agglutinate logarithmic parasites when used at
appropriate concentrations (Andrade, A.F. and Saraiva, E.M. 1999). Selection was
originally performed with multiple rounds of ricin at 100 µg/ml (King, D.L. and Turco,
S.J. 1988). As mentioned previously, L. donovani produces roughly 100 pMol of LPG /
107 parasites, while JABBA produces only 30.
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A. Lectin Resistance
Traditionally, lectins have been used to determine if the LPG cap is accessible
(Sacks, D.L., et al. 1995). Logarithmic L. donovani has been shown to be agglutinated by
both ConA, being able to bind the Man(α1,2)Man found on the terminus of some caps,
and PNA which recognizes the terminal galactose found on a number of caps. ConA,
PNA, and RCA 120 were all tested. Previously published data shows approximately 10
µg of ricin, or 100 µg of ConA or PNA, is sufficient to agglutinate L. donovani (Andrade,
A.F. and Saraiva, E.M. 1999). The previously mentioned critical density designations for
logarithmic and stationary phase were maintained throughout the entire experiment.
When exposed to 100 µg/ml of ConA, 7% of logarithmic phase L. donovani
parasites and 25% of logarithmic phase JABBA parasites showed resistance. In stationary
phase, 14% of L. donovani and 30.73% of JABBA parasites were resistant to ConA
(Figure 5.2, top panel). The L. donovani resistant percentages are similar to those
published (Sacks, D.L., et al. 1995). The difference between L. donovani and JABBA in
both logarithmic and stationary phases was found to be significant, but the difference
between logarithmic and stationary phases of JABBA was not.
After treatment with 100 µg/ml of PNA only 1% of logarithmic and 6.27% of
stationary L. donovani parasites showed resistance, similar to published data. Of treated
JABBA parasites, 8.5% showed resistance in logarithmic phase, and 16% showed
resistance in stationary phase (Figure 5.2, bottom panel). The difference in resistance
values between L. donovani and JABBA in both logarithmic and stationary phases was
found to be significant, as was the difference between logarithmic and stationary JABBA.
Additionally, both L. donovani and JABBA parasites were grown in the presence of 100
µg/ml of PNA and the LPG was extracted. The total amount of LPG extracted from both
parasites doubled, showing selection with PNA in both parasites increases the total
apparent amount of surface LPG.
Selection experiments were repeated with 10 µg/ml RCA 120, which is
considered to have similar agglutination properties as PNA at 100 µg/ml concentration.
Approximately 2.4% of logarithmic L. donovani parasites showed ricin resistance, as did
about 3.5% of stationary L. donovani. Approximately 7.05% of logarithmic JABBA
parasites showed ricin resistance, as did 15.5% of stationary JABBA parasites (Figure
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5.3). A significant difference between L. donovani and JABBA was found in both phases,
as well as between logarithmic and stationary JABBA with a <0.005 p-value.
B. Galactose Oxidase Accessibility
In previous publications, the accessibility of terminal galactose to the caps of LPG
on whole cells to galactose oxidase has been critical in making the observation on the
accessibility of the caps to molecules (Sacks, D.L., et al. 1995). Unfortunately, measuring
this required reduction with tritiated sodium borohydride, and the reaction’s byproduct:
tritiated hydrogen gas. We attempted to make use of the sensitivity of capillary
electrophoresis to avoid use of tritiated sodium borohydride. By comparing the reduction
of total galactose in caps treated with galactose oxidase and comparing it to caps from
untreated parasites, one could calculate the relative amount of galactose available to
galactose oxidase. Greater than 85% of galactose on logarithmic phase L. donovani is
accessible to galactose oxidase, while only 35% is available on stationary phase parasites.
This 3-fold change is similar to the change in radioactivity between L. donovani
logarithmic phase and stationary phase in previously published data. In logarithmic
phase JABBA had approximately 31% terminal galactose to galactose oxidase, in
stationary phase only 8% of its terminal galactose was accessible (Table 5.1).
3. Discussion
Previously, ricin-resistance mutants were characterized if they were defective in LPG
synthesis. To date the four mutants characterized have been R2D2, C3PO, OB1, and
JEDI (Descoteaux, A., et al. 2002;Descoteaux, A., et al. 1998;King, D.L. and Turco, S.J.
1988;Ma, D., et al. 1997)The LPG of two of these mutants did not possess a terminal
galactose, and only JEDI’s LPG contained a full repeating unit. Despite possessing a
terminal galactose, JEDI demonstrated ricin-resistance, leaving the exact mechanisms of
ricin selection unknown. Of the entire set of recovered mutants, two were overexpressing mutants: JABBA and HUTT. HUTT was abandoned due to abnormally low
levels of LPG synthesis. JABBA is the first large LPG mutant characterized, allowing for
the investigation of its specific mechanism of ricin resistance.
The most significant lectin data was found using peanut agglutinin and ricin, both of
which recognize terminal galactose. In both cases, there is a significant difference in
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resistance between L. donovani and JABBA at both logarithmic and stationary phases,
but also between the logarithmic and stationary JABBA parasites. These differences
suggest that the number of repeating units was the greatest influence on ricin resistance.
Previous data has shown that LPG is helical in nature (Homans, S.W., et al. 1992), and
that the only major LPG structural change in L. donovani from procyclic phase to
metacyclic phase is the number of repeating units. This change in LPG length is
potentially responsible for the cap becoming “cryptic” or otherwise inaccessible to lectins
(Sacks, D.L., et al. 1995). This is further supported by the stark increase in resistance of
JABBA from logarithmic to stationary phases. The presence of a significant difference in
resistance between JABBA logarithmic and L. donovani stationary parasites suggests that
the addition of glucose to the caps confers some additional resistance to terminal
galactose binding lectins.
While only 10 µg/ml of ricin was used compared to the original selection levels of
100 µg/ml, the densities for mutagenesis suggest the parasites were selected using what
we now define as stationary parasites. Original work states that parasites were selected
when grown to densities of 2.0 x 106 to 2.0 x 107 parasites/mL (Iovannisci, D.M. and
Ullman, B. 1984;King, D.L. and Turco, S.J. 1988), and JABBA shows the repeating unit
increase and loss of cap glucosyl residues starting at 3.0 x 106 parasites/mL. As originally
selected the parasites had an average repeating unit length of 42, substantially higher than
the logarithmic phase repeating unit length of 30.
ConA most often recognizes Man(α1,2)Man, a structure found in L. donovani caps.
The Man(α1,2)Man cap is not as dominant an isoform in JABBA cap structures
compared to its prominence in L. donovani, thus explaining JABBA’s phase independent
resistance to ConA.
Total LPG collected nearly doubled in both L. donovani and JABBA when exposed to
peanut agglutinin. L. donovani binds to the insect gut via galectins: lectins that recognize
galactose (Kamhawi, S., et al. 2004). If that is the case, selection via terminal galactose
lectins during stationary phase would identify parasites which successfully release from
the insect gut. An increase in the number of molecules of LPG on the cell surface would
only be relevant to the survival of the parasite once it has entered the mammalian
bloodstream (Franke, E.D., et al. 1985;Green, P.J., et al. 1994). LPG protects against
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complementation and other factors that would cause inevitable parasite death if they
reached the cell surface.
Using galactose oxidase, the relative percentage of surface galactose accessible can
be calculated in order to determine just how cryptic the cap is. Capillary electrophoresis
was used in lieu of radioactivity. In theory, capillary electrophoresis could have
quantified total moles of product, but this proved difficult as the galacto-hexodialdose
product does not necessarily label as a single peak; the labeling scheme for capillary
electrophoresis relies the monosaccharides having only one reducing end, it has two. Due
to this fact, direct analysis of the dialdose product was not possible, so the quantification
of accessible galactose was done against untreated caps and normalizing to the total
amount of mannose in the sample. This did not appear to affect the data for LD4
(Sudanese L. donovani), but decrease in galactose in stationary JABBA caps could’ve
helped skew the data.
Two hypotheses can be made to put all of the ricin and other lectin resistance data in
perspective in regards to the life cycle of the parasite. At 15 repeating unit LPG, the
procyclic promastigote binds to lectins in the sand fly gut, we can surmise from the
resistance data the parasite has the best chance of survival with a greater number of LPG
molecules on the cell surface and with greater than 30 repeating units on LPG molecules.
It remains unclear exactly why parasites resistant to PNA have an apparent increased
amount of LPG on the cell surface, but one possibility is that parasites with fewer
molecules agglutinate as the lectins reach the layers of the glycocalyx closer to the cell
surface and binding to terminating galactosyl residues present. These differences could
be investigated using LPG collected from parasites using the ability for red blood cells to
be opsonized, or how parasites survive complement if they’ve been exposed to PNA.
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Table 5.1. The percentage galactose available to galactose oxidase based on capillary
electrophoresis quantification. Averages were determined using seven experiments

Parasite

Growth Stage

Galactosyl Residues
oxidized (%)

LD4

JABBA

Logarithmic

>85

Stationary

35

Logarithmic

31

Stationary

8
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A.

B.

Figure 5.1: Two potential models for ricin-resistance of JABBA parasites. A. This
model relies on the use of abnormal cap structures in logarithmic phase to block binding
of ricin to terminal β-galactose. B. The entire cap becomes inaccessible due to curvature
of the LPG due to the number of repeats. This model could result in increased binding in
logarithmic or stationary phase parasites.
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p-Value <.01

Figure 5.2: Agglutination profiles of logarithmic and stationary parasites exposed to
Concanavalin A and Peanut Agglutinin. Top panel: Logarithmic and stationary
parasites of both LD4 and JABBA were exposed to Concanavalin A for 30 minutes, and
the free cells were counted. The p-values between parasites in the same phase are <.01.
Bottom panel: Logarithmic and stationary parasites were exposed to Peanut Agglutinin
for 30 minutes and free cells were counted. The p-values between parasites in the same
phase were <.01. . Minimum of 4 separate counts was used for each average. Error bars
are representative of standard deviation.
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p-Value <.0001

Figure 5.3: Agglutination profiles of logarithmic and stationary parasites exposed to
Ricin. Parasites grown in logarithmic and stationary phase were exposed to ricin (RCA120) at 10 µg/ml concentration for 30 min. Free cells were counted. The p-value
comparing parasites of the same phase was <.005. Averages were a minimum of 4
separate runs. Error bars are representative of standard deviation. Stationary phase
JABBA was most likely the structure found on the parasites originally selected after
mutagenesis.
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Chapter VI
Conclusions and Future Directions
The creation of lpg- mutants in our lab using mutagenesis with N-methyl-N’nitroso-N-nitroguanidine and selection by ricin agglutinin has resulted in the direct
identification of the genes LPG1, LPG2, LPG3, and LPG4A (Descoteaux, A., et al.
2002;Descoteaux, A., et al. 1998;Hong, K., et al. 2000;King, D.L. and Turco, S.J.
1988;Ma, D., et al. 1997;Ryan, K.A., et al. 1993b) and aided in the identification of
LPG4B and LPG4C. LPG4A has a primary function in the elongation of glycan chains on
proteophosphoglycans, while the other five genes are directly involved in the synthesis of
LPG. While selection with ricin agglutinin was designed to identify parasites with
truncated LPG; the identification of hyper-phosphoglycosylated mutants from this project
was completely unexpected. The goals of this project were to determine the structure of
JABBA’s LPG, determine the cause of its ricin resistance, and identify any changes in
glycosyltransferases involved in LPG biosynthesis.
JABBA has a unique larger LPG structure; in all phases, JABBA LPG has a
higher molecular weight than wild-type. The repeating unit structure is the same as wildtype, being identified as 6Gal(β1,4)Man(α1)PO4 (Figures 3.3 and 3.4), but JABBA LPG
has an increase in the number of repeating units compared to wild-type. Logarithmic
phase JABBA LPG has 30 repeating units, stationary phase LPG has 47, in comparison to
wild-type’s 15 repeating units in logarithmic phase and 30 in stationary phase (Table
3.1). Logarithmic phase JABBA starts as “metacyclic length” LPG and continues to
increase in size as it would during a normal life cycle.
JABBA LPG also differs in its cap isoforms. JABBA has a total of six cap
isoforms, the three dominant isoforms found in wild-type and three containing a
Glc(β1,2)Man linkage (Table 3.3). The unique isoforms are Glc(β1,2)Man ,
Gal(β1,4)[Glc(β1,2)]Man, and Gal(β1,4)[Glc(β1,2)Man(α1,2)]Man. The Glc(β1,2)Man
linkage is not found in any other parasite. The β-glucose is stage specific, and the
glucose-containing cap isoforms are downregulated as the parasite progresses from
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logarithmic to stationary phase, starting at a relative density in culture of 3.0 x 106
parasites/ml (Figure 3.8).
Differences in the eMPT and β-glucosyltransferase activity are responsible for the
structural differences in JABBA LPG (Figures 4.1 and 4.2), as the activity of both of
these enzymes in JABBA is double that in wild-type. No statistically significant
difference in the iMPT activity of JABBA and wild-type was found, but a slight increase
in mean activity is evident. Analyzing the product of LD4 (wild-type Sudanese L.
donovani) β-glucosyltransferase assay helped explain how a mutagenized parasite from a
species that does not have an in vivo active β-glucosyltransferase seemingly had an active
one.
The β-glucosyltransferase product from LD4 (wild-type Sudanese L. donovani
)and JABBA characterized as a βGal-(βGlc)-Man trisaccharide, similar to the
trisaccharide found on JABBA caps. This activity in both the parent and JABBA differed
from Mongi (L. donovani Indian isolate) that has a β-glucosyltransferase which adds to
the galactose of repeating units and cap, and explains that the enzyme, which only active
in vitro in the wild-type, when upregulated would explain the unique cap structures.
Results of agglutination with peanut agglutinin, ricin agglutinin, and concanavalin
A, along with the reduced accessibility of terminal galactose to galactose oxidase,
suggests that the primary mechanism for resistance comes from the number of repeating
units causing the caps to become cryptic, not the unique cap structures. Stationary
parasites, which do not contain the unique cap isoforms, showed the greatest resistance to
agglutination by lectins and the least accessibility of terminal galactose to galactose
oxidase. The structure of the LPG found at this density was most likely selected after
mutagenesis based on the densities the parasites at which ricin selection occurred.
The initial structural and biosynthetic analysis of JABBA LPG allows for a few
important conclusions to be drawn. The significant increase in unagglutinated parasites
after exposure to ricin or peanut agglutinin, along with a decrease in the amount of
galactose available to galactose oxidase between logarithmic and stationary phase
JABBA parasites, shows that every repeating unit over 30 increases the likelihood that
the cap is going to become “cryptic” and inaccessible to lectins. Those parasites resistant
to lectins have an increased amount of LPG collected from the cell surface, even in wild75

type, while the structure of LPG is not overtly changed. The cause is unknown, but a
denser glycocalyx would provide greater protection as the parasite attempts to infect a
mammalian host. Lastly, LD4( wild-type L. donovani Sudanese isolate) contains a βglucosyltransferase active in vivo that is regulated at some point post-translationally to
inhibit its activities. This β-glucosyltransferase differs from Mongi (Indian isolate), as it
uses mannose as the acceptor instead of galactose.
Further studies of JABBA are complicated compared to the original lpg- mutants
as up regulation of enzymes does not allow for identification of the mutation in JABBA
parasites using the traditional cosmid approach. A diagram of the ways JABBA can be
studied is found in Figure 6.1. To rule out any transcriptional up-regulation in JABBA,
quantitative PCR could be used to look at transcript levels of LPG4C, the eMPT. This
may not be conclusive due to the polycistronic transcripts produced by Leishmania
parasites. The best mechanism to further study JABBA would be to identify the putative
β-glucosyltransferase from the L. donovani genome, and trace the difference from each
strain and identify the differences. Putative β-glucosyltransferases could also be
identified using bioinformatics data from other trypanosomes.
The other, simpler, question to tackle is if it is truly an upregulation resulting in
an increased amount of enzyme found in JABBA, or if it is point mutations found in the
eMPT. Data from the LPG4A, LPG4B, LPG4C project could allow for sequencing of
LPG4C from JABBA to eliminate the possibility of a point mutation in LPG4C affecting
the rate. Antibodies from LPG4A created from previous work could potentially be used
to total the amount of all three enzymes and compare, but will not elucidate the two
eMPTs and the iMPT. Little work has been done on the genetic regulation of Leishmania
parasites, particularly involving metacyclogenesis, but JABBA has the potential to
increase understanding.
JABBA provides a unique method for identifying how certain changes affect the
parasite throughout its life cycle. JABBA parasites should be studied with both the
logarithmic and stationary phases in the sand fly and mouse models of infectivity. In the
sand fly, it should be identified if the parasite can bind at all to the sand fly gut and, if so,
does the glucose containing cap structure affect binding. We saw some minor, but not
significant evidence it had an effect on lectin binding, as in many cases the logarithmic
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JABBA parasites were more resistant to lectins than stationary L. donovani parasites.
Stationary phase parasites should also be checked for their ability to bind to the sand fly
gut, but based on the lack of galactose oxidase sensitivity one would find it unlikely.
In the mouse model of infectivity, the required parasite burden to produce an
infection should be measured in both logarithmic and stationary phase, with the overall
immune response compared to that of normal metacyclic parasites. There is a distinct
possibility in both phases that there is a stronger or altered immune response as either the
glucose present in logarithmic phase caps or the increase in repeating units could change
the innate immune response. Current data have shown the responses from TLR2 and
TLR4 could vary based on these changes (Ibraim, I.C., et al. 2013). With these studies on
infectivity and the immune response, the ability to trigger the complement cascade along
with the response of other blood serum factors should be examined as it could be
comparatively altered. JABBA provides a unique view that we have not had for studying
the parasite and its life cycle, since many hypo-phosphoglycosylated LPG mutants exist
but JABBA is the first hyper-phosphoglycosylated LPG mutant.
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Figure 6.1: Flow-chart of ways to pursue future study of JABBA.
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